AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

HARGREAVE HALE AIM VCT PLC

Annual Report Sep 30, 2019

4834_10-k_2019-09-30_fc0b8610-fa4a-406c-bced-363fa89ec16f.pdf

Annual Report

Open in Viewer

Opens in native device viewer

Planting seeds for growth

Annual report and accounts for Hargreave Hale AIM VCT plc year ended 30 September 2019

Contents

1. Strategic report
Financial highlights 3
Chairman's statement 4
The Company and its business model 8
Investment objectives, policy and strategy 9
Key performance indicators 11
Principal risks and uncertainties 14
Long term viability statement and other policies 15
Investment manager 16
Investment manager's report 17
Investment portfolio summary 19
Top ten investments 23
2. Governance
Board of Directors 27
Directors' report 28
Directors' remuneration report 31
Corporate governance 35
Report of the Audit Committee 40
Statement of directors' responsibilities 42
3. Financial Statements
Independent Auditor's report 44
Income statement 49
Balance sheet 50
Statement of changes in equity 51
Statement of cash flows 53
Notes to the financial statements 54
Alternative performance measures 68
Glossary of terms 69
Shareholder information 70
Company information 71
Notice of Annual General Meeting 72

Coming into bloom

1

2 Hargreave Hale AIM VCT / Annual Report and Accounts 2019 Hargreave Hale AIM VCT / Annual Report and Accounts 2019

Strateg ic report

Financial highlights

The strategic report has been prepared by the Directors in accordance with the requirements of Section 414A of the Companies Act 2006.

Dividends paid per calendar year Discount to NAV

Pence for share

Pence for share

(1)

Sep 14 Sep 15 Sep 16 Sep 17 Sep 18 Sep 19

Earnings per share 2019 2018
Revenue return (0.0 1 )p (0.19)p
Capital return (11.0 4 )p 11.81p
Combined return (11. 05)p 11.62p

-10

-8

Financial Calendar
Record date for annual dividend 10 January 2020
Payment of annual dividend 11 February 2020
Annual General Meeting 4 February 2020
Announcement of half-yearly results for the six months ending 31 March 2020 June 2020
Payment of interim dividend (subject to Board approval) July 2020

(1) Alternative performance measure defi nitions and illustrations can be found on page 68.

Chairman's statement

Introduction

Following the success of our offer for subscription which raised £25 million, I would like to welcome a large number of new shareholders.

Performance

At 30 September 2019, the net asset value (NAV) per share was 70. 60 pence which after adjusting for the dividends paid gives a NAV total return since inception of 125.7 5 pence. The earnings per share combined return for the year was a loss of 11. 05 pence (comprising a revenue loss of 0.0 1pence and a capital loss of 11.0 4pence). The NAV total return (NAV plus dividends paid) for the period was a loss of 13. 5% compared to a loss of 19.4% in the FTSE AIM All-share total return Index in the year to 30September 2019.

It is disappointing to report a negative return for the year, which started poorly amidst some challenging market conditions within the fi rst quarter of the fi nancial year. Subsequent performance was better, albeit with only modest gains posted in the quarters as many small companies traded through a highly uncertain political and economic environment.

Investments

During the year, the investment manager, Hargreave Hale Limited , invested £12. 0 million into 1 4 Qualifying Companies. The fair value of Qualifying Investments at 30 September 2019 was £79. 6 million invested in 79 AIM companies and 9 unquoted companies. £65.0 million was held in a mix of cash and nonqualifying equities; more detail can be found in the investment manager's report on page 1 7.

Dividend

In the 12 month period to 30 September 2019, the Company paid dividends totalling 5.15pence. A special dividend of 1 penny was paid on 24 October 2018, a fi nal divid end of 2.65 pence in respect of the previous fi nancial year was paid on 8 February 2019 and an interim dividend of 1.50 pence paid on 26 July 2019 (interim 2018: 1.75 pence).

On 31 October 2019, the Company announced a special dividend of 1.75 pence returning to shareholders proceeds arising from the realisation of some of the Company's underlying investments. The dividend payment was made on 28 November 2019 to shareholders on the register on 8 November 2019.

A fi nal dividend of 2. 25 pence is proposed (2018: 2.65 pence) which, subject to shareholder approval at the Annual General Meeting, will be paid on 11 February 2020 to ordinary shareholders on the register on 10 January 2020.

The Directors continue to maintain their policy of targeting a tax free dividend yield equivalent to 5% of the year end NAV. The ability to pay dividends is also dependent on the Company's available reserves and cash resources, the Companies Act and the Listing Rules. The policy is non -binding and at the discretion of the Board. Dividend payments may vary from year to year in both quantum and timing. Dividends will vary with investment performance; in good years, the Directors may consider a higher dividend payment; in poor years, the Directors may reduce or even pay no dividend.

Buybacks

In total, 4,076,170 shares (nominal value £40,762) were purchased during the year at a cost of £2,902,402 and an average price of 71.20 pence per share. A further 615,077 shares have been purchased since the year end at an average price of 66. 78 pence per share.

The Board continues to target a share price discount of 5% to the NAV per share (as measured against the mid-price) for market purchases. It should be emphasised that this target is non-binding and depends upon a range of factors, including the Company's liquidity, its shareholder permissions and market conditions.

The Company has a 5 year average share price discount of 5.37%.

Offer for subscription

The Directors of the Company announced on 19 September 2018 the launch of a new offer for subscription for shares to raise up to £20 million, together with an over-allotment facility of up to a further £10 million. The offer was approved by shareholders of the Company at a general meeting on 19 October 2018 and was open to both new and existing shareholders. On 28 November 2018, the Company announced it had received valid applications in excess of £20 million and accordingly, the Directors confi rmed they were releasing £5 million of the available £10 million over-allotment facility. On 24 January 2019, the Company announced it had received valid applications in respect of the full £5 million over-allotment facility and closed the offer for further applications at that time. On 11 April 2019, the Directors announced the offer was closed.

The offer resulted in gross funds being received of £25.0 million and the issue of 31.4 million new shares in the Company.

Cost effi ciency

Your Board reviews costs incurred by the Company on a regular basis and are focused on maintaining a competitively low ongoing charges ratio. The year end ongoing charges ratio was 2.0 5% when calculated in accordance with the AIC's "Ongoing Charges" methodology. This approach includes indirect costs

incurred by underlying investment funds held by the Company such as the Marlborough Special Situations Fund. As the investment advisor to the Marlborough Special Situations Fund, Hargreave Hale Limited makes an adjustment to its investment management fee to ensure the VCT is not charged twice for their services.

Expenses are expected to rise in the current year. Most of this is driven by changes to the investment management, administration, custody and directors fees and refl ect investments made by the Company and Canaccord Genuity Wealth Limited to strengthen the board of directors, expand the size of the fund management team working on the VCT (to support the investment into private companies) and improve the governance and administration of the Company.

Total costs as measured under the EU rules and published in the Company's Key Information Document are also monitored by the Board. This measure is calculated using a different methodology including some costs which are not treated as ongoing charges under the AIC's approach and therefore shows a higher fi gure than the published ongoing charge ratio. The current KID is published on the Company's web site www.hargreaveaimvcts.co.uk.

Hargreave Hale Limited integration with Canaccord Genuity Wealth Limited

The integration of Hargreave Hale Limited's private client business into Canaccord Genuity Wealth Limited (CGWL) was completed on 8 April 2019. The fund management business remains within Hargreave Hale Limited, a wholly owned subsidiary of CGWL. The ultimate parent company of CGWL is Canaccord Genuity Group Inc.

New agreements

Following the acquisition of Hargreave Hale Limited by CGWL the Company has entered into a series of new agreements with CGWL.

As previously announced, on 5 April 2019 the Company entered into a new custody agreement with CGWL. Under the terms of the new custody agreement the annual custody fee was increased from £10,000 to £30,000. On 25 June 2019, the Company entered into new administration and secretarial contracts with CGWL. As part of the new arrangements Stuart Brookes was replaced by CGWL as the Company's named company secretary. Under the new agreements the annual fee for administration services increased from £110,000 to £195,000. The fee for secretarial services remains unchanged at £17,000.

Investment management will continue to be provided by Hargreave Hale Limited under a new agreement which commenced on 25 June 2019. As previously disclosed the annual fee payable to the investment manager increased to 1.7% with effect from 1 April 2019. The annual fee continues at this rate under the new agreement. The investment manager's previous entitlement to earn a performance fee has been removed under the updated arrangements.

Related party transactions

As the Company's investment manager, Hargreave Hale Limited is a related party to the Company for the purposes of the Listing Rules. As Hargreave Hale Limited and CGWL are part of the CGWM group, CGWL also falls within the defi nition of a related party as they are part of the same group as the investment manager.

In addition to the new agreements set out above the Board has resolved to increase the Directors' fees. Oliver Bedford, a non-executive director of the Company is also an employee of the investment manager and the fee in respect of his position on the Board is paid to the investment manager.

The Company announced the increase in the investment manager's fees and the new custody arrangements on 16 May 2018 and 10 April 2019 respectively.

When aggregated with the commission received by the investment manager in relation to the offer agreement entered into on 19 September 2018 the increase in the annual administration fees, custody fees and the director's fee paid to Hargreave Hale Limited in respect of Oliver Bedford's appointment are classifi ed as smaller related party transactions as defi ned in LR 11.1.10R.

VCT fund management team

On 1 July 2019, Oliver Bedford assumed the role of lead manager of the Hargreave Hale AIM VCT plc. He is supported by Lucy Bloomfi eld (co-manager) with whom he works closely to deliver the investment strategy. Giles Hargreave continues to act as a co-manager to the VCT focusing primarily on supporting the delivery of the non-qualifying investment strategy through the direct investment of the Company's capital into listed equities as permitted by the VCT rules.

Board composition

As disclosed in the interim report, following a review, the Directors decided it would be benefi cial to the Company to improve diversity and to recruit another independent non-executive director with skills that are complementary to the existing directors.

I am delighted to welcome Angela Henderson to the Board as a non-executive director appointed on 29 October 2019. Angela is a non-executive director at Credit Suisse Asset Management Limited with over 20years experience in the fi nancial services sector having worked at Citco Fund Services and the equities divisions of Deutsche Bank and Barclays. Please see page 27 Board of directors for further details.

I am also delighted to welcome Louise Page who joined the Company as a Board Observer on 29 October 2019. Louise is currently chief fi nancial offi cer and director of corporate services for the National Trust for Scotland. Louise is a chartered accountant and prior to joining the National Trust for Scotland worked in the fi nancial services industry from 1999 to 2018.

I have been Chairman of your Board since the Company was founded in 2004. I will be stepping down as Chairman at the AGM on 4 February 2020, at which point David Brock will succeed me. I will take over as Chairman of the Audit Committee on an interim basis and in due course we will recruit an additional director at which time I intend to retire fully.

Given our need to appoint new directors and our wish to attract the best available talent, we felt it important to review the directors' remuneration to ensure it remained competitive with the industry. Directors remuneration was last reviewed in 2015. Having compared remuneration levels across the VCT industry and considered the increased level of engagement the Board has with the Company (in part a response to the increasingly complex regulatory environment), it was agreed that the Chairman should receive £32,000 and the other directors £25,000, with an extra £3,000 for the Chairman of the Audit Committee. These changes took effect on 1 October 2019.

Shareholder event

Both your Board and the investment manager are keen to improve interaction with our shareholders. I am pleased to report that we held one shareholder eventwithin the reporting period and another post period end. Historically, these events have only drawn a modest response, typically 20-30 shareholders. In a bid to attract wider attendance, we held our most recent event at an external venue with better facilities and more convenient transport links. We were delighted to see a much improved response with 119 shareholders joining us at Everyman Cinemaon 28 November 2019.

VCT regulatory update

There were no major changes to VCT legislation announced during the period under review.

New legislation introduced through the Finance Act 2018 came into effect for your Company from 1 October 2019. The legislation requires the Company to maintain at least 80% (previously 70%) of its investments (as measured by book cost) in Qualifying Companies. As before, the Company continues to benefi t from a 3-year disregard on new capital, which is measured from the start of the fi nancial year in which the shares were issued. The legislation also now requires 30% of funds raised to be invested in Qualifying Companies within 12 months from the end of the fi nancial year in which the shares were issued.

VCT status

I am pleased to report that we continue to perform well against the requirements of the legislation and at the period end, the investment test was 9 6.6% when measured using HMRC's methodology. The investment test dropped to 8 5.3% on 1 October 2019 as shares issued in the 2016 fi nancial year fell into the calculation for the fi rst time. The Company's investment test has consistently tracked ahead of the higher threshold, giving the Board confi dence that the Company can meet this new requirement. The Company satisfi ed all other tests relevant to its status as a Venture Capital Trust.

Key information document

I am sure most of you are all too familiar with the new EU's PRIIPs regulation which came into effect in January 2018 . The intent is to increase customer protection by improving the functioning of fi nancial markets and in this instance through the Key Information Document (KID) to provide shareholders with more information about the risks, potential returns and charges within VCTs. The regulation requires the Company to publish a KID. Retail investors must now be directed to this before buying shares in the Company. The KID is published on the Company website at www.hargreaveaimvcts.co.uk/ document-library.

The KID has been prepared using the methodology prescribed in the PRIIPS regulation. Although well intended, there are widespread concerns about the application of some aspects of the prescribed methodologies to VCTs. Specifi cally, there are concerns that:

    1. the risk score may be understating the level of risk; and
    1. investment performance scenarios may indicate future returns for shareholders that are too optimistic.

The Association of Investment Companies (AIC) has engaged on this matter and it is hoped that these issues will be resolved in the future. In the meantime, the Board recommends shareholders continue to classify VCTs as a high risk investment.

Outlook

Re-reading my outlook statement from last year's annual report, it struck me how little has changed in the past year. We continue to live in 'interesting times' whilst BREXIT still dominates our political, economic and corporate landscape. Shareholder s will have their own views on this most divisive of topics, although I suspect all of us welcome the clarity that springs from the resounding Conservative win.

With the substantial majority that he now has Boris Johnson can forge ahead dealing with the EU without being defl ected by any of the extremes in his party. The sooner this is resolved the sooner we can all think of something else. I am pleased to see that markets seem to have welcomed the election result and have generally started to rise.

Sir Aubrey Brocklebank Chairman

1 9 December 2019

The company and its business model

The Company was incorporated and registered in England and Wales on 16 August 2004 under the Companies Act 1985, registered number 05206425.

The Company has been approved as a Venture Capital Trust by HMRC under Section 259 of the Income Taxes Act 2007. The shares of the Company were fi rst admitted to the Offi cial List of the UK Listing Authority and trading on the London Stock Exchange on 29 October 2004 and can be found under the TIDM code "HHV". The Company is premium listed.

In common with many other VCTs, the Company revoked its status as an investment company as defi ned in Section 266 of the Companies Act 1985 on 23 May 2006 to facilitate the payment of dividends out of capital profi ts.

The Company's principal activity is to invest in a diversifi ed portfolio of qualifying small UK based companies, primarily trading on AIM, with a view to maximising tax free dividend distributions to shareholders.

The Company is registered as a small UK Alternative Investment Fund Manager (AIFM) with a Board comprising of fi ve non-executive directors, four of whom are independent. Hargreave Hale Limited acts as investment manager whilst Canaccord Genuity Wealth Limited acts as administrator and custodian and provides the company secretary.

The Board has overall responsibility for the Company's affairs including the determination of its investment policy, however, the Board exercises these responsibilities through delegation to Hargreave Hale/Canaccord Genuity Wealth Limited as it considers appropriate.

The Directors have managed and continue to manage the Company's affairs in such a manner as to comply with Section 259 of the Income Taxes Act 2007.

Investment objectives, policy and strategy

Investment objectives and policy

Investment objectives

The Company's investment objectives are:

  • to invest in a diversifi ed portfolio of small UK based Qualifying Companies on a high risk, medium term capital growth basis, primarily being companies which are traded on AIM and which have the opportunity for signifi cant value appreciation;
  • to invest in smaller companies which may not be readily accessible to private individuals and which also tend to be more risky;
  • to maximise distributions to shareholders from capital gains and income generated from the Company's funds ;
  • targeted investment in equities which are nonqualifying investments on an opportunistic basis; and
  • to maintain the Company's exposure to small companies through an initial investment of new capital into the Marlborough Special Situations Fund pending investment into Qualifying Companies.

Asset allocation

The Company will have a range of investments in four distinct asset classes:

  • equity investments in Qualifying Companies, referred to as "Qualifying Investments". Qualifying Investments will:
  • comprise qualifying holdings for a VCT as defi ned in Chapter 4 Part 6 of the Income Tax Act 2007;
  • primarily be made in AIM companies, but the Company's investment manager will also consider NEX-quoted companies and private companies that meet the investment criteria summarised below; and
  • vary in size typically from £250,000 to £3 million by cost;
  • fi xed income securities;
  • bank deposits that are readily realisable; and
  • non-qualifying equity exposure in the form of equity exposure to UK and international equities through targeted investments made on an opportunistic basis or through an investment into the Marlborough Special Situations Fund.

Portfolio weighting (by market value)

Investment manager

The Company is managed by Hargreave Hale Limited which has been managing investments in UK Small and Micro Cap companies for 21 years and VCTs for 15 years. Hargreave Hale has a long-established reputation as a substantial investor in and a supporter of small British companies through the main market of the London Stock Exchange and AIM. As well as the Venture Capital Trust, the fund management team manages 6 unit trusts including the Marlborough Special Situations Fund, the Marlborough UK Micro-Cap Growth Fund and the Marlborough Multi-Cap Income Fund. On 1 July 2019, Oliver Bedford assumed the role of lead manager of the Hargreave Hale AIM VCT plc. He is supported by Lucy Bloomfi eld, a co-manager of the VCT with whom he works closely to deliver the investment strategy. Giles Hargreave continues to act as a co-manager to the VCT, focusing primarily on supporting the delivery of the non-qualifying investment strategy through the direct investment of the Company's capital into listed equities as permitted by the VCT rules, with support from the rest of the Hargreave Hale fund management team. The breadth of the fund management team, the scale of investment into small companies and the investment manager's track record help attract deal fl ow.

Investment strategy

Qualifying investments

The investment manager will maintain a diversifi ed and fully invested portfolio of Qualifying Investments. The primary purpose of the investment strategy is to ensure the Company maintains its status as a VCT. To achieve this, within the period under review the Company was required to have at least 70% of all funds raised from the issue of shares invested in Qualifying Investments throughout accounting periods of the VCT beginning no later than three years after the date on which those shares are issued.

Looking ahead, the VCT is now required to invest and maintain a minimum of 80% of the fund in Qualifying Investments as measured by the VCT rules, it is likely that the investment manager will target a higher threshold of approximately 85% in order to provide some element of protection against an inadvertent breach of the VCT rules. The Company's maximum exposure to a single company is limited to 15% of net assets at book cost at the date of investment.

The key selection criteria used in deciding which Qualifying Investments to make include, inter alia:

  • the strength and credibility of the management team;
  • the business plan;
  • the risk/reward profi le of the investment opportunity;
  • the quality of the fi nance function and budgetary process;
  • the strength of the balance sheet relative to anticipated cash fl ow from operations; and
  • the existing balance of investments within the portfolio of Qualifying Investments.

The investment manager follows a stock specifi c, rather than sector specifi c, investment approach and is more likely to provide growth and development capital than seed capital.

The investment manager will primarily focus on investments in companies with a quotation on AIM. The investment manager will also invest in private companies or those planning to trade on AIM. The investment manager prefers to participate in secondary issues of companies with an established track record that can be more readily assessed and often have greater disclosure of fi nancial performance. Secondary issues are often priced at an attractive discount to the market price.

Non-qualifying investments

The Company will have non-qualifying direct equity exposure to UK and international equities through targeted investments made on an opportunistic basis. This will vary in accordance with the investment manager's view of the equity markets and may fl uctuate between nil and 30% (by market value) of the net assets of the Company. The investment manager will also invest in fi xed income securities and cash.

The investment manager may invest up to 75% of the net proceeds of any issue of new shares into the Marlborough Special Situations Fund subject to a maximum of 20% (7.9% as at 30 September 2019) of the gross assets of the Company. This will enable the Company to maintain its exposure to small companies indirectly, whilst the investment manager identifi es

opportunities to invest directly into small UK companies through a suitable number of Qualifying Investments.

The Marlborough Special Situations Fund has an excellent long term track record having returned 2,866% (equivalent to an average 17.5% per annum to 30 September 2019) since Giles Hargreave took responsibility for it in July 1998.

The allocation between asset classes in the nonqualifying portfolio will vary depending upon opportunities that arise with a maximum exposure of 100% of the non-qualifying portfolio to any individual asset class.

To the extent that any future changes to the Company's investment policy are considered material, shareholder consent to such changes will be sought.

Borrowings

It is not the Company's present intention to have any borrowings. The Company does, however, have the ability to borrow a maximum amount up to 15% of the "Adjusted Capital and Reserves" amount (as such term is defi ned in the Articles of Association of the Company), which is effectively the aggregate of the nominal capital of the Company issued and paid up and the amount standing to the credit of the consolidated reserves of the Company, less specifi ed adjustments, exclusions and deductions.

Key performance indicators

The Directors consider the following Key Performance Indicators (KPIs) to assess whether the Company is achieving its strategic objectives. The Directors believe these measures help shareholders assess how effectively the Company is applying its investment policy and are satisfi ed the results give a good indication of whether the Company is achieving its investment objectives and policy. The KPIs are established industry measures.

Further commentary on the performance of these KPIs has been discussed in the chairman's statement and investment manager's report on pages 4 to 7 and 1 7 to 1 8 respectively.

1. Net asset value and total return

In the fi nancial year under review, net assets decreased from £154.8m to £144.0m. This decrease of £10.8m was made up of a loss for the year of £22. 2m, buybacks of £2.9m, dividends paid of £10.2m and offset by £24. 5m from new shares issued through the subscription. The net asset value per share decreased from 87.59p to 70. 60p resulting in a loss to ordinary shareholders of 11.8 4 pence per share (-13. 5%) after adjusting for dividends paid in the year. During the same period, the total return since inception decreased by 8.6%.

It is disappointing to report a negative return for the year which resulted from a challenging market environment in the Company's fi rst quarter in which the valuation of growth stocks was under particular pressure. Performance has subsequently stabilised and whilst negative in absolute terms is some way ahead of the FTSE AIM All-Share total return for the last 12 months.

Net asset value and total return

Pence per share

2. Ongoing charges ratio

The ongoing charges of the Company for the fi nancial year under review represented 2.0 5% (2018: 1.87%) of average net assets, which remains competitive against the whole VCT industry and similar to other AIM VCTs. This ratio is calculated using the AIC's "Ongoing Charges" methodology. Cost control and effi ciency continues to be a key focus for your Board and they are satisfi ed with the result for the year.

3. Earnings per share (basic and diluted)

The Company's earnings per share for the year ended 30 September 2019, together with those of the previous fi ve fi nancial years are shown below .

It is frustrating to report a total earnings per share loss for the year of 11. 05 pence per share. The challenging market environment previously mentioned resulted in an unrealised loss on investments of £19. 5m for the year which was the predominant cause.

Earnings per share

4. Dividends per share

The Board's policy is to target a tax free dividend yield equivalent to 5% of the year end NAV. The Board remains committed to maintaining a steady fl ow of dividend distributions to shareholders; however, dividends may vary from year to year in both quantum, depending on investment performance, and timing. The ability to pay dividends is dependent on the Company's available reserves and cash resources, the Companies Act and the Listing Rules. The policy is non-binding and at the discretion of the Board.

A total of 5.15 pence per share of dividends were paid during the year, comprised of a special dividend of 1 pence paid on 24 October 2018 and 4.15 pence of ordinary dividends. Ordinary dividends paid during the year included an interim dividend of 1.50 pence and a fi nal dividend of 2.65 pence.

A fi nal dividend of 2. 25pence per share will be proposed at the Annual General Meeting which when added to the interim dividend of 1.50 pence paid on 26 July 2019 represents a yield from ordinary dividends of 5.3% of the 30September 2019 closing NAV of 70. 60pence per share .

5. Percentage invested in qualifying companies

The investment test increased from 93.2 % to 9 6.6% in the year. The Company invested £12. 0 million into 1 4 Qualifying Companies, 5 of which were investments into new Qualifying Companies. The Board is pleased with this result. The fair value of the qualifying portfolio decreased from £87.6m to £79. 6m resulting from a combination of the above additions and unrealised losses for the period. The Board believes that the Company will continue to meet the HMRC defi ned investment tests on an ongoing basis.

In addition, the Board considers peer group comparative performance whilst recognising that the relevant peer group is very small. Performance is also measured against the Company's closest benchmark the FTSE AIM All-share total return and this is shown in the graph below. The Director's consider this to be the most appropriate benchmark from a shareholder's perspective, however, due to the investment restrictions placed on a VCT it is not wholly comparable.

Within our portfolio of equity investments, 62% of the portfolio is invested in constituents of the AIM All-Share. The FTSE 250 represented 12% and the FTSE 100represented 10%. If private companies are excluded from the portfolio, the exposure to the AIM All-Share rises to 71%.

VCT vs benchmark

Source: Bloomberg For further details please refer to the investment managers report on pages 1 7 to 1 8.

Principal risks and uncertainties

The Directors acknowledge that they are responsible for the effectiveness of the Company's risk management and internal controls and periodically review the principal risks faced by the Company at board meetings. The Board may exercise these responsibilities through delegation to Hargreave Hale Limited and Canaccord Genuity Wealth Limited as it considers appropriate. The principal risks facing the Company relate to the Company's investment activities and include risks stated below:

Risk Potential Consequence How the Board mitigates risk
Venture Capital Trust approval risk –
the Company operates in a complex
regulatory environment and faces a
number of related risks. A breach of
Section 259 of the Income Taxes Act
2007 or the Finance Act could result
in the disqualifi cation of the Company
as a VCT.
Loss of VCT approval could
lead to the Company losing its
exemption from corporation tax
on capital gains, shareholders
losing their tax reliefs and in
certain circumstances being
required to repay the initial tax
relief on their investment.
To reduce this risk, the Board has appointed the
investment manager, who has signifi cant experience
in venture capital trust management and reports to
the Board regularly throughout the year. In addition,
to provide further formal assurance, the Board has
appointed Philip Hare & Associates LLP to monitor
compliance with regulations and provide half yearly
compliance reports to the Board.
Investment risk – Many of the
Company's investments are held in
small, high risk companies which are
either listed on AIM or privately held.
Investment in poor quality
companies could reduce the
capital and income return to
shareholders. Investments
in small companies are often
illiquid and may be diffi cult to
realise.
The Board has appointed an investment manager with
signifi cant experience of investing in small companies.
The investment manager maintains a broad portfolio
of investments, individual Qualifying Investments
rarely exceed 5% of net assets, and holds regular
company meetings to monitor investments and
identify potential risk. The fund's liquidity is monitored
on a regular basis by the investment manager.
The Company is exposed to potentially
destabilising economic and political
developments such as recession,
sharp changes in interest rates or the
UK's exit from the European Union.
Events such as these could
have a negative impact on stock
markets and the value of the
Company's investments.
Regular dialogue with the manager provides the Board
with assurance that the manager is following the
investment policy agreed by the Board and appraises
the Board of the portfolio's current positioning in the
light of prevailing market conditions.
Compliance risk – The Company is
required to comply with the rules
of the UK Listing Authority, the
Companies Act, Accounting Standards,
the General Data Protection
Regulation and other legislation. The
Company is also a small registered
Alternative Investment Fund Manager
("AIFM") and has to comply with the
requirements of the AIFM Directive.
Failure to comply with these
regulations could result in a
delisting of the Company's
shares, fi nancial penalties, a
qualifi ed audit report or loss of
shareholder trust.
Board members have considerable experience of
operating at senior levels within quoted businesses.
They have access to a range of advisors including
solicitors, accountants and other professional bodies
and take advicewhen appropriate.
Operational risk and outsourcing –
Failure in the investment manager/
administrator or other appointed
third party systems and controls or
disruption to its business.
Failures could put the assets
of the Company at risk or
result in reduced or inaccurate
information being passed to the
Board or shareholders. Quality
standards may be reduced
through lack of understanding
or loss of control.
The Company has in place a risk matrix and a set
of internal policies which are reviewed on a regular
basis. It has written agreements in place with its third
party service providers. The Board receives regular
reports from the investment manager, administrator
and custodian to provide assurance that appropriate
oversight is in place. Additionally the Board receives
a control report from the Company's registrars on
an annual basis. Where tasks are outsourced to
other third parties, reputable fi rms are used and
performance is reviewed periodically.
Political risk – The VCT scheme is
brought to an end as a result of a
change in government policy.
Loss of future tax incentives
leading to the VCT sector as a
whole becoming unattractive to
investors.
The Board keeps abreast of current thinking through
contact with industry associations and its advisors.
Key personnel risk – A change in
the key personnel involved in the
management of the portfolio.
Potential impact on investment
performance.
The Board discusses key personnel risk and
resourcing with the investment manager periodically.
The VCT team within the investment manager has
increased in size over the last eighteen months which
helps to mitigate this risk.

Additional risks and further details of the above risks and how they are managed are explained in note 1 5 of the fi nancial statements. Trends affecting future developments are discussed in the chairman's statement on pages 4 to 7 and the investment manager's report on pages 1 7 to 1 8.

Long term viability statement and other policies

In accordance with provision C.2.2 of the UK Corporate Governance Code, the Directors have carried out a robust assessment of the principal risks relating to the Company. This assessment has been carried out over a longer period than the 12 months required by the 'Going Concern' provision. The Board conducted this review for a period of fi ve years, which was selected because it:

  • falls in line with the Company continuation vote and investors minimum holding period to retain tax relief; and
  • covers a suffi cient period for all funds raised to comply with HMRC investment test rules.

The Board considers the viability of the Company as part of its continuing programme of monitoring risk. The Company has a detailed risk control framework, documented procedures and forecasting model in place to reduce the likelihood and impact of risk taking that exceeds the agreed levels by the Board. These controls are reviewed by the Boardon a regular basis.

Details of the continuation vote are contained in the Company's Articles of Association. At the Annual General Meeting to be held in 202 5, the Directors shall propose an ordinary resolution that the Company should continue as a venture capital trust.

The Board has considered the Company's fi nancial position and its ability to meet its liabilities as they fall due over the next fi ve years taking into account the following factors in its assessment of the Company's future viability:

  • the Company maintains a broad portfolio of investments including approximately £40.4 million invested in non-qualifying investments and a further £24.6 million in cash at the year end. The Company therefore has suffi cient liquidity which is monitored quarterly;
  • the Company is well invested against the HMRC investment test and ended the year at 9 6.6% invested in Qualifying Companies. The Board anticipates that there will continue to be suitable Qualifying Investments available over the next fi ve years;
  • the ongoing charges ratio of the Company for the year end was 2.0 5%, which is competitive for the VCT sector;
  • the fi nancial position of the Company at 30 September 2019 was strong with no debt or gearing; and
  • the Company has suffi cient procedures in place to identify, monitor and control risk.

In assessing the Company's future viability, the Board has assumed that investors will wish to continue to have exposure to the Company's activities, that performance will be satisfactory and the Company will continue to have access to suffi cient capital.

Based on this assessment, the Directors have a reasonable expectation that the Company will be able to continue in operation and meet its liabilities as they fall due over the next fi ve years.

Other policies

Diversity

The Board comprises four male non-executive directors and one female non-executive director with a diverse range of experience, skills, length of service and backgrounds. The Board considers diversity when reviewing Board composition and has made a commitment to consider diversity when making future appointments. The Board will always appoint the best person for the job. It will not discriminate on the grounds of gender, race, ethnicity, religion, sexual orientation, age or physical ability.

Environmental responsibility

The Board conducts the Company's affairs responsibly and expects the investment manager to consider environmental matters when appropriate. The Company offers electronic communications where acceptable to reduce the volume of paper it uses.

Employee, human rights, social and community issues

The Board seeks to conduct the Company's affairs responsibly and expects the investment manager to consider employee, human rights, social and community issues when fulfi lling their role. As the Company has no employees it does not maintain any specifi c policies in relation to these matters.

Prospects

The prospects and future development of the Company are discussed in detail in the outlook section of the chairman's statement on page7.

The strategic report is approved, by order of the Board of Directors.

Sir Aubrey Brocklebank

Chairman 1 9 December 2019

Investment manager

Established in 1897, Hargreave Hale has evolved into a leading UK small cap fund manager. In September 2017, the fi rm became a member of the Canaccord Genuity Wealth Limited (CGWL) group of companies and a wholly owned subsidiary of Canaccord Genuity Group Inc.

The lead manager of the VCT is Oliver Bedford. He is supported by Lucy Bloomfi eld (co-manager) who works closely with Oliver Bedford to deliver the investment strategy. Giles Hargreave continues to act as a co-manager to the VCT focusing primarily on supporting the delivery of the non-qualifying investment strategy through the direct investment of the Company's capital into listed equities as permitted by the VCT rules. The VCT management team is also supported by the rest of Hargreave Hale's fund management team of 16. The fund management team manages approximately £ 5.0 billion (30 Sep 201 9), including approximately £ 3.2 billion invested in small companies. Along with the scale of the investment in small companies and their track record, the breadth of the team and their reach into the market help attract Qualifying Investment deal fl ow.

Oliver Bedford BSc MCSI

Oliver Bedford graduated from Durham University with a degree in Chemistry. He served in the British Army for 9 years before joining Hargreave Hale in 2004. Oliver is the lead manager of the VCT and supports other unit trusts as part of the fund management team.

Lucy Bloomfi eld

Lucy joined the Hargreave Hale VCT team in August 2018. Prior to this she spent 8 years as an analyst and UK Small & Mid-cap fund manager at BlackRock before her most recent role as a European Small & Mid-cap fund manager with Ennismore Fund Management. Lucy graduated from Durham University in 2007 with a degree in Economics and is a CFA charterholder.

Giles Hargreave Giles Hargreave is the head of Hargreave Hale's fund management team and manager of the Marlborough Special Situations Fund. He also co-manages the Marlborough UK Micro Cap Growth Fund and the Marlborough

UK Nano-Cap Growth Fund.

Other members of the fund management team include David Walton, Siddarth Chand Lall, Richard Hallett, George Finlay, Guy Feld, Will Searle and Eustace Santa Barbara, (pictured from left to right below).

In fund management Assets

Invested in small companies

Track record in fund management

Meetings with

annum

companies per

Source: Hargreave Hale Limited (as at 30 September 2019).

Investment manager's report

Introduction

This report covers the 2018/19 fi nancial year, 1 October 2018 to 30 September 2019. The investment manager's report contains references to movements in the net asset value (NAV) per share and total return per share (NAV per share plus distributed earnings per share). Movements in the NAV per share do not necessarily mirror the earnings per share (EPS) reported in the accounts and elsewhere, which convey the profi t after tax of the Company within the reported period as a function of the weighted average number of shares in issue for the period.

Investment performance measures contained in this report are calculated on a pence per share basis and include realised and unrealised gains and losses.

Investment report

The year under review started off with the markets fi rmly on the back foot. The political landscape, at home and abroad, was contentious and confrontational. There were questions about the outlook for the US economy amidst an escalating Sino-American trade war; the US yield curve inverted. This all made for a diffi cult market environment, particularly for growth stocks. Global equity markets suffered a painful sell off in late 2018, making it the worst year for shares since 2008. 2019 started with soothing comments from the Chairman of the Federal Reserve, who talked of a 'patient' approach to monetary policy tightening. This was enough to bring investors back into the equity markets, where there was clear value on offer and an attractive dividend yield, 5% in the case of FTSE 100. In many respects, little has changed since then . In response, many central banks loosened monetary policy or signalled that they might, in some cases supported by new fi scal programmes. Fears of a 2020 US recession faded away.

As we moved through the early part of the year, it became increasingly clear that parliament would not support a 'no deal' departure from the EU, triggering a notable rally in those companies whose fortunes are most directly tied to the domestic economy. This optimism did not fi lter all the way through the market and, by and large, investors have stayed away from the smallest companies on the public markets.

The uncertainty of the past year has depressed deal fl ow, mostly obviously IPO activity on AIM, which has been at its lowest in a decade. Fortunately, we have a broad portfolio of existing investee companies, many of whom require further growth capital. This, coupled with our ability to provide capital through off-market transactions, has ensured we were able to deploy funds in line with our original budget. The drop off in AIM IPOs this year mirrored the trend on the main market. We expect to see a pick up in activity next year.

We have always viewed our non-qualifying equity as discretionary risk and have therefore continued to run a more defensive portfolio; we took further steps in the summer to reduce risk and improve liquidity.

Performance

In the twelve months to 30 September 2019, the NAV decreased from 87.59p to 70. 60p. A total of 5.15 pence per share was paid in dividends, giving investors a total return of -11.8 4 pence per share, which translates to a loss of 13. 5%. During the same period, the FTSE AIM All-Share total return lost 19.4%, whilst the FTSE All Share total return gained 2.7%.

The Qualifying Investments made a net contribution of -9. 47 pence per share. The adjusting balance was the net of non-qualifying portfolio losses, running costs and investment income.

Blackbird was the top performing Qualifying Investment (+85.5%, +0.48 pence per share) as a signifi cant contract with the US Department of State, collaboration with Google and increased adoption by several US new channels for its innovative cloud-based video post-production editing platform was announced over the period. Gousto was the second largest contributor to positive performance (+27.2%, +0.47 pence per share), as the company continues to progress in line with its strategy. Angle (+86.2%, +0.42 pence per share), Cohort (+33.2%, +0.30 pence per share) and Crosswords (+48.3%, +0.25 pence per share) were also signifi cant contributors over the period.

Disappointingly, our biggest drawdowns came from our more established companies. The most notable was Learning Technologies (-31.8%, -1.48 pence per share). Following strong outperformance in the previous year, a combination of the market sell off, a poorly timed management share sale and negative research note saw the share price fall 60% to a low of 62p during the year. The shares staged a recovery as the company upgraded guidance driven by better margin performance. Other losses came from Honest Brew ( -77.6%, -0.83pence per share) following a challenging period over Christmas 2018. The company has developed a revised business plan that includes a new membership model and range expansion. Trading has been good through the autumn and in the run up to Christmas. Zoo Digital (-35.2%, -0.99 pence per share), Creo (-35.1%, -0.91 pence per share) and Loop Up (-85.9%, -0.79 pence per share) also endured meaningful falls in their share price. Zoo Digital and Creo have rallied strongly off their 2019 lows and we remain positive on their prospects.

We invested £12. 0m into 1 4 Qualifying Companies over the period, comprising 9 existing Qualifying Companies

(3 private), 2 secondary placings, 2 IPOs and 1 additional private company.

Within the qualifying portfolio we reduced our investments in Blackbird, Crossword Cybersecurity, Learning Technologies and Renalytix. In each case, we were selling into strength. We lost Sanderson to a takeover by private equity. We also made complete exits from Fulcrum Utilities and Velocity Composites due to growing concerns over the outlook for both companies. Post period end, we lost a further two Qualifying Companies (APC Technology and Synnovia (formerly Plastics Capital)) to bids from private equity.

Portfolio structure

The VCT is comfortably through the HMRC defi ned investment test and ended the period at 9 6.6% invested as measured by the HMRC investment test. By market value, the VCT had a 55. 3% weighting to Qualifying Investments.

The allocation to non-qualifying equity investments increased from 18.5% to 20.1%. We continued to make use of the Marlborough Special Situations Fund as a temporary home for proceeds from fundraising; the allocation decreased from 9.0% to 7.9%. The Marlborough Special Situations Fund returned a loss of 10.1% in the period (- 0.72 pence per share). The non-qualifying direct equity investments contributed -0.60pence per share to the overall loss. Within the period, Future plc returned +154% (+0.83 pence per share), making it the single biggest positive contributor to the net asset value. Investors responded positively to strong execution of the company's mixture of organic and acquisition led growth, which drove performance ahead of market expectations. The period ended with no fi xed income investments and an increase in the cash weighting from 16.1% to 17.1%.

The HMRC investment tests are set out in Chapter 3 of Part 6 Income Tax Act 2007, which should be read in conjunction with this section of the annual report. Funds raised by VCTs are fi rst included in the investment tests from the start of the accounting period containing the third anniversary of the date on which the funds were raised. Therefore, the allocation of Qualifying Investments as defi ned by the legislation can be different to the portfolio weighting as measured by market value relative to the net assets of the VCT.

Post period end update

Global equity markets have been more benign post period end, with US indices hitting new highsas some of the more recent political risks fall away, at least for now. Markets have also found support from the more dovish stance adopted by many central banks and, in the case of the UK and elsewhere, talk of fi scal stimulus. The General Election has produced some welcome clarity on how and when the UK will exit the EU. This, along with confi rmation that we will continue to operate within a free market economy, should support a more benign backdrop for the small domestically orientated companies that we invest in. The NAV has fallenfrom 70.60 pence to 69.90 pence in the period to 13 December 2019, equivalent to a gainof 1.5% after adjusting for the 1.75pence special dividend paid on 28 November 2019.

We continued to deploy capital into Qualifying Companies in line with the budget, despite the lack of IPO activity on AIM. £ 3.0m has been invested into existing Qualifying Companies including 1 private compan y.

As of 1 8 December 2019, the share price of 6 6.50 pence represented a discount of 4.9% to the last published net asset value per share.

For further information please contact:

Oliver Bedford

Lead Manager

Registered offi ce: Hargreave Hale AIM VCT plc, 41 Lothbury London, EC2R 7AE 0207 523 4837

1 9 December 2019

Investment portfolio summary

As at 30 September 2019

Net Assets % at
30/9/19
Cost £000 Cumulative
Movement in
value £000
Valuation
£000
Change in
Value for the
year £000(2)
Market COI(1)
Qualifying Investments
Learning Technologies Group plc 3.92 2,487 3,153 5,640 (2,867) AIM Y
SCA Investments Ltd (Gousto) 3.13 2,484 2,026 4,510 965 Unlisted Y
Hardide plc 2.63 3,136 651 3,787 507 AIM Y
Ideagen plc 2.62 1,992 1,777 3,769 (336 ) AIM N
Zoo Digital Group plc 2.5 3 2,266 1,383 3,649 (1,985 ) AIM N
Creo Medical Group plc 2.30 2,329 983 3,312 (1,790) AIM Y
Cohort plc 1.7 3 619 1,879 2,498 622 AIM Y
Craneware plc 1.68 125 2,296 2,421 (813) AIM Y
Aquis Exchange plc 1.66 765 1,620 2,385 274 AIM Y
Oxford Genetics Ltd 1.52 2,186 - 2,186 - Unlisted Y
Blackbird plc 1.38 777 1,213 1,990 892 AIM N
Abcam plc 1.31 55 1,831 1,886 (477) AIM Y
Angle plc 1.29 1,158 701 1,859 861 AIM N
Diaceutics plc 1.29 1,550 305 1,855 306 AIM Y
Beeks Financial Cloud Group plc 1.13 1,038 586 1,624 (754) AIM Y
Zappar Ltd 1.11 1,600 - 1,600 2 Unlisted N
Mexican Grill Ltd (A Preference
Shares)
1.11 1,013 586 1,599 218 Unlisted N
Surface Transforms plc 1.08 980 568 1,548 485 AIM Y
Eagle Eye Solutions Group plc 1.03 1,642 (162) 1,480 287 AIM Y
Crossword Cybersecurity plc 0.90 877 423 1,300 423 AIM Y
Science in Sport plc 0.87 1,479 (229) 1,250 (480) AIM Y
Quixant plc 0.80 1,209 (53) 1,156 (1,430 ) AIM Y
Escape Hunt plc 0.77 1,959 (856) 1,103 (704) AIM Y
Laundrapp Ltd (Ordinary & "D"
Shares)
0.72 2,236 (1,197) 1,039 (427) Unlisted N
EKF Diagnostics Holdings plc 0.69 565 431 996 (57 ) AIM Y
Location Sciences Group plc 0.65 1,000 (67) 933 (67) AIM Y
Cloudcall Group plc 0.63 1,287 (376) 911 13 AIM N
Clearstar Inc 0.61 720 160 880 (255) AIM Y
Equals Group plc 0.61 750 126 876 (634) AIM N
AnimalCare Group plc 0.59 720 135 855 (204) AIM N
Infi nity Reliance Ltd (My 1st Years 'D'
shares)
0.59 1,500 (647) 853 (39 5) Unlisted Y
Everyman Media Group plc 0.52 600 151 751 (173) AIM Y
Infi nity Reliance Ltd (My 1st Years 'C'
shares)
0.47 1,000 (318) 682 (317 ) Unlisted Y
Gfi nity plc 0.46 1,526 (863) 663 (691) AIM N
K3 Business Technology Group plc 0.44 270 366 636 (84) AIM Y
Belvoir Group plc 0.44 762 (127) 635 6 AIM N
Maxcyte Inc Com Stk USD0.01 (DI) 0.44 932 (298) 634 (653 ) AIM Y
Yourgene Health plc 0.43 521 99 620 - AIM N
Instem plc 0.42 297 31 2 609 11 6 AIM Y
CentralNic Group plc 0.42 588 12 600 (38) AIM Y
Intelligent Ultrasound Group plc 0.40 800 (219) 581 (30) AIM N
Idox plc 0.39 135 432 567 (65) AIM Y
Tristel plc 0.39 543 15 558 (12) AIM N
Synnovia plc 0.38 478 73 551 54 AIM N
The Property Franchise Group plc 0.37 377 156 533 61 AIM Y
PCI-PAL plc 0.36 810 (290) 520 21 AIM Y
Honest Brew Ltd 0.3 4 2,200 (1,707) 493 (1,704) Unlisted N
Globaldata plc 0.32 173 284 457 117 AIM Y
Reneuron Group plc 0.31 606 (165) 441 322 AIM N
bigblu Broadband plc 0.30 347 84 431 11 AIM Y
Cumulative Change in
Net Assets % at
30/9/19
Cost £000 Movement in
value £000
Valuation
£000
Value for the
year £000(2)
Market COI(1)
Qualifying Investments
ULS Technology plc 0.29 770 (356) 414 (657) AIM N
Portr Ltd (Ordinary & "A" Shares) 0.2 8 1,788 (1,378) 410 (819) Unlisted N
APC Technology Group plc 0.28 291 111 402 106 AIM Y
Maxcyte Inc Com Stk USD0.01 (DI/
REG S)
0.27 582 (188) 394 (188) AIM Y
Ilika plc 0.26 507 (129) 378 82 AIM Y
Intercede Group plc 0.24 305 38 343 55 AIM Y
WANDisco plc 0.23 346 (1 0) 336 (176 ) AIM N
Vertu Motors plc 0.23 600 (270) 330 (101 ) AIM Y
Faron Pharmaceuticals Oy 0.22 2,218 (1,898) 320 (1) AIM N
KRM22 plc 0.22 619 (309) 310 (358 ) AIM Y
Fusion Antibodies plc 0.19 414 (141) 273 (12) AIM Y
Loopup Group plc 0.18 1,204 ( 944) 260 ( 1,581) AIM Y
DP Poland plc 0.17 1,390 ( 1,143) 247 ( 1,260) AIM Y
i-nexus Global plc 0.15 700 (478) 222 (406) AIM Y
C4X Discovery Holdings plc 0.15 500 (283) 217 (283) AIM Y
Osirium Technologies plc 0.14 858 (663) 195 (656) AIM Y
Mexican Grill Ltd (Ordinary Shares) 0.12 113 65 178 24 Unlisted N
Renalytix AI plc 0.11 81 82 163 82 AIM Y
TrakM8 Holdings plc 0.11 486 ( 325) 161 ( 464) AIM N
Mirriad Advertising plc 0.11 610 (452) 158 (169) AIM N
Universe Group plc 0.10 210 (67) 143 8 AIM N
MYCELX Technologies Corporation plc 0.10 361 (220) 141 (244 ) AIM Y
Lidco Group plc 0.09 307 (184) 123 (46 ) AIM N
Mirada plc 0.08 96 16 112 43 AIM N
Pressure Technologies plc 0.08 170 (60) 110 (20) AIM N
Portr Ltd ("B" Shares) 0.07 100 - 100 - Unlisted N
Omega Diagnostics Group plc 0.07 129 (32) 97 (32) AIM N
Verona Pharma plc 0.06 221 ( 138) 83 (115) AIM Y
Egdon Resources plc 0.05 158 (85) 73 (23) AIM Y
Redcentric plc 0.03 42 3 45 (2) AIM N
Genedrive plc 0.03 5 4 (1 5) 39 (1 5) AIM N
SEC Newgate S.p.A. 0.02 106 (75) 31 (75) AIM N
Hawkwing plc 0.02 135 (113) 22 (113) AIM N
Laundrapp Ltd ("A" Preference Shares) 0.01 213 (195) 18 (195) Unlisted N
Microsaic Systems plc 0.01 26 (10) 16 (14) AIM N
Tasty plc 0.01 40 ( 31) 9 ( 31) AIM Y
Midatech Pharma plc 0.01 53 ( 46) 7 (22) AIM N
Mporium Group plc - 33 (31) 2 (23) AIM N
Fusionex International plc - - - - - Unlisted N
Abal Group plc - - - - - AIM Y
FlowGroup plc - 26 (26) - - Unlisted N
Infoserve Group plc - - - - - Unlisted N
Paragon Entertainment Ltd - 87 (87) - (78) Unlisted N
Total - Qualifying Investments 55. 27 72, 418 7, 176 79, 594 ( 18, 658 )
Non qualifying investments
Marlborough Special Situations Fund 7.9 4 10,96 5 47 5 11,440 (1,47 3 ) Unlisted Y
Total unit trusts 7.9 4 10,96 5 47 5 11,440 (1,473 )
Future plc 1.84 944 1,700 2,644 1,631 Main Y
JD Sports Fashion plc 1.19 892 825 1,717 560 Main Y
Melrose Industries plc 1.01 1,434 21 1,455 177 Main Y

Royal Dutch Shell plc 1.00 1,327 110 1,437 (176) Main Y

Net Assets % at Cumulative
Movement in
Valuation Change in
Value for the
30/9/19 Cost £000 value £000 £000 year £000(2) Market COI(1)
BP plc 0.93 1,471 (130) 1,341 (460 ) Main Y
Halma plc 0.89 822 458 1,280 353 Main Y
IntegraFin Holdings plc 0.86 815 417 1,232 243 Main Y
Hilton Food Group plc 0.85 1,183 39 1,222 (247 ) Main Y
Dechra Pharmaceuticals plc 0.78 854 267 1,121 239 Main Y
Ascential plc 0.77 1,069 42 1,111 (91) Main Y
Tesco plc 0.71
0.70
906
870
118
137
1,024
1,007
119
112
Main
Main
Y
Y
Fisher (James) & Sons plc
Anglo American plc 0.65 727 209 936 37 Main N
XP Power Ltd 0.55 871 (76) 795 (67) Main Y
Spirax-Sarco Engineering plc 0.5 4 633 152 785 151 Main N
Glaxosmithkline plc 0.5 4 707 78 785 78 Main Y
Cineworld Group plc 0.53 980 (223) 757 (223) Main Y
Zotefoams plc 0.51 750 (14) 736 (10) Main Y
Trainline plc 0.4 8 681 17 698 18 Main Y
TT Electronics plc 0.46 656 9 665 9 Main Y
NMC Health plc 0.42 570 40 610 (304) Main Y
Oxford Biomedica plc 0.42 956 (349) 607 (366) Main Y
On the Beach Group plc 0.40 627 (56) 571 (200) Main Y
Cohort plc 0.38 36 7 18 5 552 13 8 AIM Y
Countryside Properties plc 0.37 585 (49) 536 (18) Main Y
Prudential plc 0.31 470 (28) 442 6 Main N
Ocean Wilsons (Holdings) Ltd 0.28 535 (126) 409 (126) Main Y
Everyman Media Group plc 0.25 293 71 364 (84) AIM Y
Horizon Discovery Group plc 0.24 374 (26) 348 (120) AIM Y
Vesuvius plc 0.24 448 (106) 342 (178 ) Main Y
Renishaw plc 0.23 374 (44) 330 (56) Main Y
GoCo Group plc 0.22 457 (135) 322 (54) Main Y
Quixant plc 0.15 159 55 214 (264) AIM Y
Mexican Grill Ltd (A Preference
Shares)
0.12 135 37 172 23 Unlisted N
MYCELX Technologies Corporation plc 0.11 298 (134) 164 (283 ) AIM Y
Ricardo plc 0.11 236 (77) 159 (26) Main Y
Mexican Grill Ltd (Ordinary Shares) 0.02 26 (4) 22 3 Unlisted N
Hargreave Hale AIM VCT plc - - 1 1 - Main Y
Genagro Ltd - - - - - Unlisted Y
Total - equity non-qualifying
investments
20.0 6 25,502 3,41 1 28,913 544
Total - non-qualifying investments 28.0 0 36,467 3,88 6 40,353 (92 9)
83. 27 1 08,885 1 1,062 119,947 ( 19, 587)
Total investments 17.1 1 24,638
Cash at bank (0. 38 ) ( 543)
Prepayments & accruals
Net assets
100.00 144,042

(1) COI – Co investments with other funds managed by Hargreave Hale at 30 September 2019.

(2) The change in fair value has been adjusted for additions and disposals in the year and as such does not reconcile to the unrealised total in note 7. The difference is £43 k which is the total of 22 full investment disposals in the year.

Investments by market sector as at 30 September 201 9

Investments by market sector as at 30 September 201 8

The investments listed below are either listed, headquarted or registered outside the UK:

Listed Headquartered Registered
Listed investments:
Clearstar Inc UK USA Cayman Islands
Faron Pharmaceuticals Oy UK Finland Finland
Horizon Discovery Group plc UK UK and USA UK
Maxcyte Inc Com Stk USD0.01 (DI) UK USA USA
Maxcyte Inc Com Stk USD0.01 (DI/REG S) UK USA USA
MYCELX Technologies Corporation plc UK USA USA
NMC Health plc UK UAE UK
Ocean Wilsons (Holdings) Ltd UK Bermuda Bermuda
Renalytix AI plc UK USA UK
Royal Dutch Shell plc UK Netherlands UK
SEC Newgate S.p.A. UK Italy Italy
WANDisco plc UK UK and USA Jersey
XP Power Ltd UK Singapore Singapore
Unlisted private companies:
Fusionex International plc Malaysia Jersey
Genagro Ltd Jersey Jersey
Paragon Entertainment Ltd UK Cayman Islands

Top ten investments

As at 30 September 2019 (by market value)

The top ten equity investments are shown below; each is valued by reference to the bid price, or in the case of unquoted companies, the investment manager will apply one or more valuation techniques according to the nature, facts and circumstances of the investment. Forecasts, where given, are drawn from a combination of broker research and/or Bloomberg consensus forecasts and exclude amortisation, share based payments and exceptional items. Forecasts are in relation to a period end for which the company results are yet to be released. Forecasts are not shown for private companies. The net asset fi guresand net cash values are from published accounts in most cases.

Learning Technologies Group plc 112.8p
Investment date November 2014 Forecasts for the year to December 2019
Equity Held 0.75% Turnover (£'000) 130,300
Av. Purchase Price 49.7p Profi t/(loss) before tax (£'000) 36,800
Cost (£'000) 2,487 Net cash/(debt) June 2019 (£'000) (13,853)
Valuation (£'000) 5,640 Net assets June 2019 (£'000) 172,763

Company description

Learning Technologies Group provides a comprehensive and integrated range of e-learning services and technologies to corporate and government clients. The Group offers end-to-end learning and talent solutions ranging from strategic consultancy, through a range of content and platform solutions to analytical insights that enable corporate and government clients to meet their performance objectives.

SCA Investments Ltd (Gousto) (unquoted) 6,738.0p
Investment date July 2017 Results for the year to December 2018
Equity Held 1.72% Turnover (£'000) 49,284
Av. Purchase Price 3,711.0p Profi t/(loss) before tax (£'000) (16,544)
Cost (£'000) 2,484 Net Cash/(debt) December 2018 (£'000) 16,447
Valuation (£'000) 4,510 Net Assets December 2018 (£'000) 24,550
Income recognised in the period 0

Company description

Founded in February 2012, Gousto is an e-commerce company offering recipe kit boxes which include fresh ingredients for step-by-step chef designed recipes to be made at home. Shoppers select meals from a variety of options on Gousto's e-commerce platform. Gousto then delivers the pre-proportioned ingredients to the doorstep, along with instructions on how to prepare the meal.

Hardide plc 74.0p
Investment date March 2005 Forecasts for the year to September 20 20
Equity Held 12.06% Turnover (£'000) 6,000
Av. Purchase Price 61.3p Profi t/(loss) before tax (£'000) (800)
Cost (£'000) 3,136 Net cash/(debt) September 2019 (£'000) 4,595
Valuation (£'000) 3,787 Net Assets September 2019 (£'000) 7,698

Company description

Hardide is the leading global innovator and provider of advanced tungsten carbide coatings that signifi cantly increase the working life of critical metal components operating in abrasive, erosive, corrosive and chemically aggressive environments.

Ideagen plc 146.0p
Investment date December 2014 Forecasts for the year to April 2020
Equity Held 1.17% Turnover (£'000) 58,000
Av. Purchase Price 77.2p Profi t/(loss) before tax (£'000) 15,800
Cost (£'000) 1,992 Net cash/(debt) April 2019 (£'000) (1,301)
Valuation (£'000) 3,769 Net Assets April 2019 (£'000) 73,682

Company description

Ideagen is a supplier of compliance-based information management software with operations in the UK and the United States. The company specialises in enterprise governance, risk and compliance and healthcare solutions for organisations operating within highly regulated industries. Ideagen provides complete content lifecycle solutions that enable organisations to meet their regulatory and quality compliance standards, helping them to reduce costs and improve effi ciency.

Zoo Digital Group plc 79.0p
Investment date April 2017 Forecasts for the year to March 2020
Equity Held 6.21% Turnover (\$'000) 35,000
Av. Purchase Price 49.1p Profi t/(loss) before tax (\$'000) 700
Cost (£'000) 2,266 Net cash/(debt) September 2019 (\$'000) (6,864)
Valuation (£'000) 3,649 Net assets September 2019 (\$'000) 5,203

Company description

Zoo Digital is a leading provider of cloud-based dubbing, subtitling, localisation and distribution services for the global entertainment industry. Zoo's clients are some of the best-known brands in the world including major Hollywood studios, global broadcasters and independent distributors. Zoo's point of difference in the marketplace is its development and use of innovative cloud technology that ensures that content is localised in any language and delivered to all the major online platforms such as Amazon, iTunes, Google and Hulu with reduced time to market, higher quality and lower costs.

Creo Medical Group plc 144.0p
Investment date December 2016 Forecasts for the year to December 2019
Equity Held 1.89% Turnover (£'000) 300
Av. Purchase Price 101.3p Profi t/(loss) before tax (£'000) (17,100)
Cost (£'000) 2,329 Net cash/(debt) June 2019 (£'000) 38,280
Valuation (£'000) 3,312 Net Assets June 2019 (£'000) 45,727

Company description

Creo Medical is a medical device company focused on the emerging fi eld of surgical endoscopy, a recent development in minimally invasive surgery. Creo Medical was founded in 2003, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

Cohort plc 526.0p
Investment date February 2006 Forecasts for the year to April 2020
Equity Held 1.42% Turnover (£'000) 149,400
Av. Purchase Price 170.0p Profi t/(loss) before tax (£'000) 20,600
Cost (£'000) 986 Net cash/(debt) October 2019 (£'000) (6,794)
Valuation (£'000) 3,051 Net Assets October 2019 (£'000) 74,135

Company description

Cohort plc provides electronic and surveillance technology solutions. The Company offers electronic warfare operational support, secure communication systems and networks, test systems and data management. Cohort serves defense and security, transport, offshore energy and other commercial markets.

Future plc 1,224.0p
Investment date May 2018 Forecasts for the year to September 20 20
Equity Held 0.27% Turnover (£'000) 305,833
Av. Purchase Price 436.9p Profi t/(loss) before tax (£'000) 64,367
Cost (£'000) 944 Net cash/(debt) September 2019 (£'000) (40,300)
Valuation (£'000) 2,644 Net assets September 2019 (£'000) 213,400

Company description

Future plc is a global multi-platform media company. The company is behind successful brands in specialist consumer and B2B sectors including technology, gaming & entertainment, music, creative & photography, home interest, education and television.

Craneware plc 2,470.0p
Investment date September 2007 Forecasts for the year to June 2020
Equity Held 0.37% Turnover (\$'000) 76,800
Av. Purchase Price 128.0p Profi t/(loss) before tax (\$'000) 19,800
Cost (£'000) 125 Net cash/(debt) June 2019 (\$'000) 47,611
Valuation (£'000) 2,421 Net Assets June 2019 (\$'000) 59,835

Company description

Craneware develops and sells billing software analysis tools for the United States healthcare services sector. The company's software automates the checking process, aids in cash fl ow and revenue generation and ensures accurate submission of claims and management of compliance risks.

Aquis Exchange plc 480.0p
Investment date October 2016 Forecasts for the year to December 2019
Equity Held 1.83% Turnover (£'000) 6,700
Av. Purchase Price 153.9p Profi t/(loss) before tax (£'000) (1,000)
Cost (£'000) 765 Net cash/(debt) June 2019 (£'000) 11,212
Valuation (£'000) 2,385 Net Assets June 2019 (£'000) 13,888

Company description

Aquis Exchange is an independent, pan-European cash equities trading venue with a unique, subscription based, pricing model. Aquis Exchange uses its own highly-performant trading technology, which is developed in-house. Aquis Exchange's technology is also available for licencing to third parties via the Company's software division, Aquis Technologies.

The future unfolds

26 Hargreave Hale AIM VCT / Annual Report and Accounts 2019

Governance

Board of Directors

Sir Aubrey Brocklebank After qualifying as a chartered accountant and following a career in corporate fi nance and venture capital, Aubrey assumed his fi rst role within the VCT industry in 1997. Since then he has gone on to become one of the most experienced directors within the industry. Aubrey maintains a wide range of business interests and has been a director of six AIM listed companies. Aubrey has been Chairman since the Company's inception. He is chairman of Downing VCT 4 plc and a director of Edge Performance VCT.

Oliver Bedford

Oliver graduated from Durham University with a degree in Chemistry. He served in the British Army for 9 years before joining Hargreave Hale in 2004. Oliver is the lead manager of the VCT and supports the other unit trusts as part of the fund management team. Oliver was appointed in December 2016.

David Brock

An experienced company chairman in both private and public companies and a former main board director of MFI Furniture Group plc, David joined the Board in September 2010. David is chairman of Draper Esprit VCT plc, Episys Group Ltd, Primrose Group Ltd and Honest Brew Ltd and a non- executive director of Puma VCT 12 plc.

Ashton Bradbury

Ashton Bradbury was appointed in May 2018. He has previously held roles at Charterhouse Tilney, Hill Samuel Investment Management and HSBC Asset Management Europe and was, until 2014, a fund manager with Old Mutual Global Investors where he established its UK small and mid-cap equities team. Ashton is currently a non- executive director of Standard Life UK Smaller Companies Trust PLC and is a director of Golf Union of Wales Limited.

Angela Henderson

Angela Henderson was appointed on 29 October 2019. Angela is a non- executive director at Credit Suisse Asset Management Ltd. She was European legal counsel for Citco Fund Services before working in the equities divisions of Deutsche Bank and Barclays from 2000 to 2015. She was an investor and director of PharmaSys Ltd, a software development company until its sale and non-executive chair at Qube Research & Technologies Ltd during its management buy out. She is a governor at Chelsea & Westminster HospitalNHS Foundation Trust. Angela is a graduate (LLB Fr Hons) of the University of Leicester and solicitor of the Supreme Court of England and Wales.

Directors' report

For the year end 30 September 2019

The Directors present their report together with the audited fi nancial statements of the Company for the year from 1 October 2018 to 30 September 2019, incorporating the corporate governance statement on pages 3 5 to 3 9. The principal activity of the company has been outlined in the strategic report on page 8.

Directors

The Directors of the Company during the year were Sir Aubrey Brocklebank (Chairman), David Brock, Oliver Bedford and Ashton Bradbury. Angela Henderson was appointed on 29 October 2019. Brief biographical details are given on page 2 7.

Directors' interests

The Directors' interests (including those of connected persons) in the issued share capital of the Company are outlined in the director's remuneration report on page 3 4. There is no minimum holding requirement that the Directors need to adhere to.

There have been no changes to the benefi cial interests of Directors between 30 September 2019 and the date of this report.

Directors' and offi cers' liability insurance

All directors and offi cers benefi t from qualifying third party indemnity insurance cover.

Disclosable interests

No director is under contract of service with the Company and other than as disclosed in note 1 4, no contract existed during or at the end of the year in which any director was materially interested and which was signifi cant in relation to the Company's business.

Revenue and dividends

The statutory loss for the year amounted to £22, 180,473 (2018: gain of £14,996,362). An interim ordinary dividend of 1.50 pence per share was paid on 26 July 2019 (2018: 1.75 pence per share). A special dividend of 1.75 pence per share was paid on 28 November 2019. The fi nal dividend of 2. 25 pence per share for the year ended 30 September 2019 is due to be paid on 11 February 2020 (2018: 2.65 pence per share).

Capital structure

The Company's capital structure is summarised in notes 1 and 1 1 to the fi nancial statements.

Voting rights in the company's shares

Details of the voting rights in the Company's shares as at the date of this report are given in note 2 to the Notice of Annual General Meeting on page 7 5.

Substantial holdings in the company

At 30 September 2019, there were two holdings of 3% and over of the Company's ordinary share capital. These holdings related to Hargreaves Lansdown (Nominees) Limited and CGWL Nominees Limited, which were 6.50% and 4.00% respectively.

At 1 8 December 2019, the Company had not been notifi ed of any signifi cant interest exceeding 3% of the issued share capital.

Share buybacks

During the year, the Company repurchased 4,076,170 ordinary shares (nominal value £40,762) at a cost of £2,902,402. The repurchased shares represent 2.3% of ordinary shares in issue on 1 October 2018. All repurchased shares were cancelled. A further 615,077 ordinary shares (nominal value £ 6,151) have been purchased since the year end at a total cost of £ 410,766.

The buyback scheme as detailed in the prospectus is offered to shareholders as a means to provide an opportunity for shareholders to sell their shares back to the Company if an exit route is desired.

The Directors believe it is in the shareholders' best interest to target a reduced buyback discount. As a guide, and subject to the Board'sdiscretion and providing that, in the opinion of the Board, there is adequate surplus cash available, the Company will consider buying back shares at a 5% discount to the last published NAV per share. The target of a share price discount of 5% of the NAV per share (as measured against the mid-price) is non-binding and at the Board's discretion.

Shares issued

During the year, the Company issued 31,379,517 ordinary shares of 1 pence per share (nominal value £313,795) which resulted in funds being received of £25,000,000. The 3.5% premium of £875,000 payable to Hargreave Hale Limited under the terms of the offer was reduced by £426,670, being the discount awarded to investors in the form of additional shares. A further reduction of £150 introductory commission was made resulting in fees payable to Hargreave Hale Limited of £448,180 which were then used to pay other costs associated with the prospectus and marketing .

Financial instruments

The Company's fi nancial instruments and principal risks are disclosed in note 1 5 to the accounts.

VCT status monitoring

The Company has appointed Philip Hare & Associates LLP as advisors on, inter alia, compliance with legislative requirements. The Directors monitor the Company's VCT status through regular reports from Philip Hare & Associates LLP.

Auditors

A resolution proposing the reappointment of BDO LLP as auditors to the Company and authorising the Directors to determine their remuneration will be put at the forthcoming Annual General Meeting.

The Directors who held offi ce at the date of approval of this directors' report confi rm that, so far as they are each aware, there is no relevant audit information of which the Company's auditors are unaware, and each director has taken all the steps that they ought to have taken as a director to make themselves aware of any relevant audit information, and to establish that the Company's auditors are aware of that information.

Greenhouse emissions

As a UK quoted company, the VCT is required to report on its greenhouse gas emissions. As it outsources all of its activities to third parties and does not have any physical assets, property, employees or operations, the Company is not directly responsible for any greenhouse gas emissions.

Amendments to the articles of association

The Company's Articles of Association may be amended by the members of the Company by special resolution (requiring a majority of at least 75% of the persons voting on the relevant resolution).

Post balance sheet events

Post balance sheet events are disclosed in note 1 7 to the fi nancial statements on page 6 7.

Future developments

Consideration of the Company's future development and prospects are contained in the chairman's statement and investment manager's report on pages 4 to 7 and 1 7 to 1 8 respectively.

Annual General Meeting

The Notice of the Annual General Meeting of the Company, to be held at 10.3 0 am on 4 February 2020 at 41 Lothbury, London EC2R 7AE is set out on pages 7 2 to 7 5 of this annual report.

A proxy form for the meeting is enclosed separately with shareholders' copies of this annual report. Those shareholders who have elected to receive information from the Company electronically will still receive a hard copy proxy form in the post. The proxy form permits shareholders to disclose votes 'for', 'against' and 'withheld'. A vote 'withheld' is not a vote in law and will not be counted in proportion of the votes for and against the resolution.

Resolutions 1 to 11 are being proposed as ordinary resolutions requiring more than 50% of the votes cast at the meeting be in favour. Ordinary resolutions include the re-election and election of company directors, further information is contained in the corporate governance statement on page 3 7 and the power to allot shares, outlined below.

Power to allot shares

Ordinary resolution number 11 will request the authority to allot up to an aggregate nominal amount of £100,000 , representing approximately 4.9% of the total share capital of the Company in issue as at the date of this document. This authority is in addition to any existing authorities. The authority sought at the forthcoming Annual General Meeting will expire 15 months from the date that this resolution is passed, or at the conclusion of the next Annual General Meeting of the Company, whichever is earlier.

Resolutions 12 and 13 are being proposed as special resolutions requiring the approval of at least 75% of the votes cast at the meeting.

Disapplication of pre-emption rights

Special resolution number 12 will request the authority for the Directors to allot equity securities for cash without fi rst being required to offer such securities to existing members. This will include the sale on a non pre-emptive basis of any shares the Company holds in treasury for cash. The authority relates to a maximum aggregate of £100,000 of the nominal value of the share capital, representing approximately 4.9% of the total share capital of the Company in issue as at the date of this document.

This authority is in addition to any existing authorities. The authority sought at the forthcoming Annual General Meeting will expire 15 months from the date that this resolution is passed or at the conclusion of the next Annual General Meeting of the Company, whichever is earlier.

Purchase of own shares

Special resolution number 13 will request the authority to purchase a maximum of 14.99% of the Company's issued Ordinary share capitalas at the date of the passing of the resolution being approximately 30,489,553 as at the date of this documentat or

betweenthe minimum and maximum prices specifi ed in resolution 13. Shares bought back under this authority may be cancelled and up to 10% may be held in treasury.

The Board believes that it is helpful for the Company to continue to have the fl exibility to buy its own shares and this resolution seeks authority from shareholders to do so.

This resolution would renew the 2019 authority, which was on similar terms. During the fi nancial year under review, the Company purchased 4,076,170 ordinary shares which were then cancelled.

The authority sought at the forthcoming Annual General Meeting will expire 15 months from the date this resolution is passed, or at the conclusion of the next Annual General Meeting of the Company, whichever is earlier.

Recommendation

The Board believes that the passing of the resolutions above are in the best interests of the Company and its shareholders as a whole and unanimously recommends that you vote in favour of these resolutions.

By order of the Board

Sir Aubrey Brocklebank

Chairman

Registered offi ce: Hargreave Hale AIM VCT plc, 41 Lothbury London, EC2R 7AE

1 9 December 2019

Directors' remuneration report

For the year end 30 September 2019

The Board presents this report which has been prepared in accordance with the requirements of The Companies Act 2006 and the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2013. Shareholders are encouraged to vote on the remuneration report annually at the Annual General Meeting and on the remuneration policy at least every three years.

Your Company's independent auditor is required to audit certain disclosures provided in this report. Where disclosures have been audited, they are indicated in this report. The auditor's opinion is included in their report on pages 4 4 to 4 8.

Statement from the Chairman of the Board in relation to Directors' remuneration matters

As part of the process of recruiting a new director we have reviewed the directors' remuneration which was last changed in 2015. It is important that the Directors' fees are competitive with those paid by other VCTs in order to attract and retain strong candidates to the Company. With that in mind, it was decided that the Chairman should receive £32,000 and the other directors £25,000 with an extra £3,000 for the Chairman of the Audit Committee. These changes took effect on 1 October 2019.

Remuneration responsibilities

As the Board consists entirely of non-executive directors it is considered appropriate that matters relating to remuneration are considered by the Board as a whole, rather than a separate remuneration committee. All directors are considered independent with the exception of Oliver Bedford who is an employee of Hargreave Hale Limited and is not therefore independent.

The remuneration policy is set by the Board, which considers whether the remuneration policy is fair and in line with comparable VCTs, together with the remuneration of each of the Directors. The Board deals with all matters relating to directors' remuneration and reporting thereon.

Policy on Directors' remuneration

The Company has no employees, so the Board's policy is that the remuneration of its directors should be fair and reasonable in relation to the time commitment and responsibilities of the Directors and in line with the remuneration paid by other listed Venture Capital Trusts and investment trusts. The Board aims to review directors' remuneration from time to time.

Fees for the Directors are determined by the Board within the limits stated in the Company's Articles of Association. The maximum permitted by the Company's Articles of Association is £200,000 per annum. The Directors are not eligible for bonuses, pension benefi ts, share options, other incentives or benefi ts . The Directors may be reimbursed for reasonable expenses incurred. The D irectors do not receive payment on loss of offi ce other than in lieu of notice period if applicable.

Directors' service contracts

It is the Board's policy that none of the Directors has a service contract. Each of the Directors has entered into an agreement with the Company when appointed. Sir Aubrey Brocklebank was appointed on 10 September 2004, David Brock on 28 September 2010, Oliver Bedford on 13 December 2016, Ashton Bradbury on 14 May 2018 and Angela Henderson on 29 October 2019. The terms of appointment provide that a director shall retire and be subject to re-election at the fi rst Annual General Meeting after appointment. The Board agreed in July 2019 that all directors will be subject to annual re-election. Either party can terminate the agreement by giving to the other at least 3 months' notice in writing.

Basis of remuneration

All of the Directors are non-executive and considered to be independent with the exception of Oliver Bedford, who is not independent. It is not considered appropriate to relate any portion of their remuneration to the performance of the Company and performance conditions have not been set in determining their level of remuneration. As the Company has no employees, it is not possible to take account of the pay and employment conditions of the employees when determining the levels of the Directors' remuneration.

The following table shows the expected maximum payment that can be received per annum by each director for the year to 30 September 2020, together with a summary of the Company's strategy and how this is supported by the current remuneration policy.

Director Role Components
of Pay
Package
Expected fees
for the year to
30 September
2020
Performance
Conditions
Company Strategy Remuneration Policy
Sir Aubrey
Brocklebank (1)
Chairman To achieve long term
£29, 388
capital growth and
to maximise tax The levels of
remuneration are
considered to be
David Brock (1) Director £30, 612 N/A free distributions
to shareholders by
investing in a diversifi ed
portfolio of small UK
companies primarily
traded on AIM.
fair and reasonable
in relation to the
time committed and
responsibilities of the
Directors and in line
with the remuneration
paid by other VCTs and
investment trusts.
Oliver Bedford Director Basic
Salary
£25,000
Ashton
Bradbury
Director £25,000
Angela
Henderson (2)
Director £23, 087

(1) Aubrey Brocklebank will step down as Chairman at the AGM on 4 February 2020, at the same time he will be appointed as Chairman of the Audit Committee. David Brock will replace Aubrey Brocklebank as Chairman on 4 February 2020, at the same time he will retire as Chairman of the Audit Committee.

(2) Angela Henderson was appointed as a director on 29 October 2019.

Annual remuneration report

The purpose of this report is to demonstrate the method by which the Board has implemented the Company's remuneration policy and provide shareholders with specifi c information in respect of the Directors' remuneration.

Under s439 of The Companies Act 2006, companies are required to ask shareholders to approve the annual remuneration paid to directors every year and to formally approve the directors' remuneration policy on an annual or on a three yearly basis. Any change to the directors' remuneration policy will require shareholder approval. As in prior years, the vote on the directors' remuneration report is an advisory vote, whilst the vote on the directors' remuneration policy is binding. Accordingly, ordinary resolutions will be put to shareholders at the forthcoming Annual General Meeting to be held on 4 February 2020, to receive and adopt the directors' remuneration report and to receive and approve the directors' remuneration policy.

At the Annual General Meeting held on 5 February 2019 the following votes were cast on the remuneration report:

Number of votes % of votes cast
For 12,882,037 91.3
Against 488,413 3.5
Discretionary 731,768 5.2
Total votes cast 14,102,218 100.0
Number of votes withheld 268,610
Total votes 14,370,828

The remuneration policy was approved by shareholders at the Annual General Meeting held 5 February 2019. Votes were cast as follows:

Number of votes % of votes cast
For 12,286,917 88.7
Against 649,408 4.7
Discretionary 917,318 6.6
Total votes cast 13,853,643 100.0
Number of votes withheld 517,185
Total votes 14,370,828

Your company's performance

The Company was incorporated on 16 August 2004 and commenced trading on 29 October 2004. The performance chart below plots the Company's ordinary share NAV total return (rebased to 100) and share price (rebased to 100) over the last 10 years compared to the total return of a notional investment in the FTSE AIM All-share total return Index over the same period. This index was chosen for comparison purposes as it represents the closest comparable equity market index, however, doesn't represent a wholly comparable fi gure due to the restrictions on which AIM companies the Company can invest in.

Source: Bloomberg

Directors' emoluments for the year (audited)

The total emoluments of each person who served as a director during the year are set out in the table below. Sir Aubrey Brocklebank is entitled to a higher fee due to his role as Chairman.

2019 2018
2019 Benefi ts in 2019 2018 Benefi ts in 2018
Fees Kind Total Fees Kind Total
£ £ £ £ £ £
Sir Aubrey Brocklebank
(Chairman)
22,500 22,500 22,500 22,500
David Brock 18,000 18,000 18,000 18,000
Oliver Bedford 18,000 18,000 25,028(1) 25,028
Ashton Bradbury 18,000 398 18,398 6,871 6,871
Total 76,500 398 76,898 72,399 72,399

(1) Fees paid to Oliver Bedford include a payment of £7,028 paid in lieu of notice for his Hargreave Hale AIM VCT 2 plc directorship.

Relative importance of spend on pay (unaudited)

The table below compares Directors' remuneration to shareholder distributions (through dividend payments and share buybacks) in respect of the fi nancial year ended 30 September 2019 and the preceding fi nancial year:

Year ended
30 September
2019
£
Year ended
30 September
2018
£
Growth
%
Directors' remuneration 76,500 84,919(1) (9.9)
Dividend paid 10,212,897 4,918,998 107.6
Share buybacks 2,902,402 2,387,356 21.6

(1) Directors' remuneration includes £19,548 paid to the directors of Hargreave Hale AIM VCT 2 plc following the acquisition. This fi gure includes employee national insurance contributions and excludes employer's national insurance contributions.

Directors' interests (audited)

The Directors' interests (including those of connected persons) in the issued share capital of the Company are outlined below. There is no minimum holding requirement that the Directors need to adhere to.

Ordinary Shares
2019 2018
Sir Aubrey Brocklebank 4,845 4,845
David Brock 42,170 42,170
Oliver Bedford 42,940 30,558
Ashton Bradbury 43,223 43,223
Angela Henderson

Angela Henderson held no shares at the date of her appointment on 29 October 2019. There are no changes to the benefi cial interests of the Directors between 30 September 2019 and the date of this report.

Taxable benefi ts

The Directors who served during the year received £398 in taxable benefi ts, all of which represent reimbursement of expenses.

Variable pay

The Directors who served during the year received no variable pay relating to the performance of the Company in the year.

Pension benefi ts

The Directors who served during the year received no pension benefi ts in the year.

Recruitment remuneration policy

The remuneration levels are designed to refl ect the duties and responsibilities of the roles and the value of time spent in carrying these out. The Board will obtain independent advice where it considers it necessary. No such advice was taken during the year under review. This policy would be used when agreeing the remuneration of any new director.

Approval

The directors' remuneration report on pages 31 to 3 4 was approved by the Board of Directors on 1 9 December 2019 and will be further subject to an advisory vote at the Annual General Meeting being held on the 4 February 2020 and every year thereafter.

Signed on behalf of the Board of Directors

Sir Aubrey Brocklebank

Chairman

1 9 December 2019

Corporate governance

For the year ended 30 September 2019

Directors' statement of compliance with the UK corporate governance code and AIC code of corporate governance

Introduction

The Board has considered the principles and recommendations of the UK Corporate Governance Code (the "UK Code") published in 2016 and the AIC Code of Corporate Governance (the "AIC Code") and put in place arrangements which it considers appropriate for a VCT to ensure proper corporate governance. The Board believes that the Company has complied with the provisions of the UK Code in the period under review except as detailed below and is also adhering to the principles and recommendations of the AIC Code.

In July 2018, the FRC issued an updated version of the UK Code and in February 2019 the AIC issued a revised version of the AIC Code both to take effect in respect of accounting periods starting on or after 1 January 2019. The Board has incorporated some of the updated requirements into this year's report and accounts ahead of time and will report fully under the new Codes, as required, for its year ending September 2020.

The UK Code includes provisions relating to:

  • the role of the chief executive;
  • executive directors' and senior managers' remuneration;
  • workforce engagement; and
  • the need for an internal audit function.

For the reasons set out in the AIC Guide and as explained in the UK Corporate Governance Code, the Board considers these provisions are not relevant to the position of Hargreave Hale AIM VCT plc, as all of the Company's day-to-day management and administrative functions are outsourced to external service providers. As a result, the Company has no executive directors, employees or internal operations and has therefore not reported in respect of these provisions.

Copies of the Codes can be found on their respective websites: www.frc.org.uk and www.theaic.co.uk.

Board leadership and purpose

The Board considers that the Company's business model remains attractive because of the potential returns available from investing in small companies and the advantageous VCT tax structure. The management of the investment portfolio has been delegated to Hargreave Hale Limited and through regular meetings with the investment manager the Board seeks to ensure that the portfolio is managed in accordance with the agreed investment objectives and policy. The

Company's investment objectives and policy are shown on pages 9 to 10. The Board seeks to control risk by ensuring that appropriate policies and controls are in place and by reviewing the Company's risk matrix every six months and taking mitigating action where necessary. A summary of the principal risks facing the Company is detailed on page 14.

The Board carries out an annual review of its own culture, practices and behaviour, the fi ndings from which are considered by the Board and any actions required are monitored. Following the 2018 review, all members of the Board received additional training on matters including Mifi d II, AIFMD and PRIIPS and the Board has strengthened its oversight procedures. The results of the most recent review showed that the Board culture remains strong and highlighted some practical steps which will be implemented over the next year to further improve the operation of the Board .

Shareholder relations

Shareholder relations are given high priority by the Board. The prime medium by which the Company communicates with shareholders is through the interim and annual report and accounts, which aim to provide shareholders with a full understanding of the Company's activities and its results. This information is supplemented by the weekly calculation of the NAV of the Company's ordinary shares, which is published via the Stock Exchange and on our website at www.hargreaveaimvcts.co.uk. Monthly factsheets and general information are also available on the website.

The Board also attend shareholder events organised by the investment manager which give them the opportunity to engage with shareholders. These events also provide an opportunity for the Directors to update the shareholders on the Company's investment objectives and investment policy. The Company held shareholder meetings on 9 November 2018 and 28 November 2019.

Shareholders have the opportunity to communicate directly with the Board at the Annual General Meeting. All shareholders are encouraged to attend the Annual General Meeting. Shareholders can also communicate with the Chairman or any other member of the Board by writing to the Company, for the attention of the company secretary at the address set out on page 71or by email to [email protected].

The Company monitors the 20% threshold for votes cast against board recommendations for a resolution but has not yet been required to take any actions in this regard.

Relations with other key stakeholders

The requirement for the Company to consider the interests of its other key stakeholders is limited as it does not have any employees. The Board considers Canaccord Genuity Wealth Limited and Hargreave Hale Limited to be its key business partners with responsibility for the provision of administration, custody, company secretarial services and investment management respectively. A representative of Hargreave Hale Limited sits on the Board and members of the Canaccord Genuity Wealth Limited senior management have had dialogue with the Board on a number of occasions during the year.

Confl icts of interest

The Directors are aware that they have a statutory obligation to avoid a situation in which they have, or potentially could have, a direct or indirect interest that confl icts with the interests of the Company. Confl icts of interest are declared at each meeting and a schedule of all the directorships held by each director is included in the board pack.

This issue has not arisen but if it were to, the company secretary would ensure that any concerns voiced by individual directors about the operation of the Board or the Company were accurately recorded in the board minutes.

Director responsibilities

The Directors have adopted a formal schedule of matters reserved for the Board which sets out the responsibilities of the Board, a copy of which is available on the Company's website. These matters include:

  • Approving strategic objectives and reviewing the Company' Strategy and investment policy to ensure it is consistent with these objectives;
  • Monitoring the performance of the investment manager and other key service providers;
  • Changes to the Company's structure and capital, this includes the policy on share buy-backs and the approval of any borrowing arrangements;
  • Approval of all fi nancial statements and any signifi cant changes in accounting practices or policies;
  • Ensuring the maintenance of a sound system of internal control and risk management;
  • Carrying out an annual review of the contracts in place with key service providers and approving any other materially strategic contracts;
  • Communication with shareholders;
  • Appointment and removal of the company secretary;
  • Determining the remuneration of the Chairman and other directors subject to the articles of association and shareholder approval as appropriate; and
  • Responsibility for all corporate governance matters.

The Directors have delegated the responsibility for the day to day investment management decisions of the Company to its investment manager Hargreave Hale Limited. The provision of administration , custodian and company secretarial services has been delegated to Canaccord Genuity Wealth Limited. Agreements are in place which clearly set out the responsibilities of these service providers to the Company.

Due to the size of the Board, the Board has not set up separate nomination, remuneration or management engagement committees on the grounds that the Board as a whole considers these matters.

The following tables set out the number of board meetings and audit committee meetings held during the year and the number of meetings attended by each individual director:

Ordinary Business
No of Board Meetings
Held Attended
Sir Aubrey Brocklebank
(Chairman)
6 6
David Brock 6 6
Ashton Bradbury 6 6
Oliver Bedford 6 6
No of Audit Meetings
Held Attended
David Brock (Chairman) 4 4
Sir Aubrey Brock lebank 4 4
Ashton Bradbury 4 4

Accountability and audit

The Directors' responsibilities for the Company's accounting records and fi nancial statements are set out on page 42. The independent auditor's report appears on pages 44 to 48.

Board and director independence

As at 30 September 2019 the Board consisted of four directors, all of whom are non-executive and all of whom are considered independent of the investment manager with the exception of Oliver Bedford who is an employee of Hargreave Hale Limited. Angela Henderson was appointed as an additional independent non-executive director on 29October 2019, subsequent to the yearend but prior to the publication of this report. Brief biographical details for the Board are shown on page 2 7.

The Chairman is Sir Aubrey Brocklebank, a non-executive director who was independent on appointment and has no confl icting relationships. The Company has announced that Sir Aubrey Brocklebank will resign as Chairman at the AGM and will be replaced by David Brock.

The Board considers that with the exception of Oliver Bedford, all of the directors remain independent. Sir Aubrey Brocklebank and David Brock have served on the Board for more than 9 years since their initial appointment but are still considered to be independent given the absence of connections with the investment manager.

As all directors are non-executives, the Board has not appointed a senior independent non-executive director as the Chairman performs the role.

Board induction and training

On appointment to the Board, directors are fully briefed as to their responsibilities and are kept regularly informed of industry and regulatory developments. There is no formal training schedule in place, directors training needs are identifi ed as part of the board evaluation process and addressed on a case by case basis.

Board meetings

The administrator and the company secretary ensure that the Directors have timely access to all relevant management, fi nancial and regulatory information to enable informed decisions to be made. The Board meets on a regular basis at least four times each year and additional meetings are arranged as necessary, the primary focus at these meetings is the review of the Company's investment performance and related matters and corporate governance.

Relationship with the investment manager

Both the schedule of matters reserved for the Board and the investment management agreement with Hargreave Hale Limited clearly set out the responsibilities of the Board and those areas of decision making over which the manager has discretion. The Board's responsibility is to review the Company's strategy and investment policy to ensure it is consistent with the objectives of the Company and monitoring the performance and investment approach of the investment manager.

The Directors have delegated responsibility for day to day investment management decisions to the investment manager and a review of the investment portfolio is carried out at quarterly board meetings. The report produced by the investment manager includes information on investment performance and fund positioning, benchmarking against both indices and peers, liquidity analysis, cash management and deal fl ow.

A review of the contractual relationship with the investment manager was carried out as part of the renegotiation of the investment management agreement . The independent non-executive directors believe that the appointment of Hargreave Hale Limited continues to be in the best interests of the Company. In reaching

this decision the independent non-executive directors have reviewed performance against the Company's key performance indicators over the long term.

Details of the investment manager's fee and termination clauses can be found on page 56.

Relationship with other service providers

The Company maintains a schedule of the contracts that it has in place with its service providers (administrator, company secretary, custodian, registrar etc). The service provided by each was reviewed by the Board in December 2019.

The Board has direct access to the company secretary, who is responsible for the timely delivery of relevant information and advising the Board on all governance matters. The appointment of Canaccord Genuity Wealth Limited as company secretary was a matter discussed and approved by the whole Board.

The Board also ha s access to independent professional advice from lawyers and tax advisors etc. This is obtainable at the Company's expense where the Directors consider it necessary in order to be able to properly discharge their responsibilities.

Board composition

Due to the size of the Board, the Board has not established a separate nomination committee and all nomination responsibilities are therefore carried out by the Board. These responsibilities include reviewing the size, structure and skills of the Board and considering any changes necessary or new appointments. Directors are required to seek approval from the Board prior to taking on any new signifi cant external appointments.

The Board agreed in July 2019 that all directors will be subject to annual re-election. The Board considers that due to their individual skills, experience and commitment Ashton Bradbury, David Brock and Oliver Bedford each merit re-election as a director.

Ashton Bradbury brings extensive asset management experience directly relevant to investing in small publicly quoted companies.

David Brock is a highly experienced company director with specifi c expertise directly relevant to investing in private companies.

Oliver Bedford is the lead manager to the Company, has strong technical knowledge covering the VCT regulations and is an effective liaison between the Company and the investment manager.

Sir Aubrey Brocklebank will step down as chairman at the AGM but will offer himself for re-election as a director. Sir Aubrey Brocklebank is one of the most experienced directors in the VCT industry and also brings accountancy skills and specifi c expertise directly relevant to investing in private companies. The Board supports Sir Aubrey Brocklebank's re-election as a director.

Angela Henderson was appointed to the Board on 29 October 2019 and so will stand for election at the forthcoming AGM. Angela Henderson brings legal skills and a strong knowledge of governance within the asset management industry. The Board believes that Angela Henderson will make a signifi cant contribution to the Company and supports her election to the Board.

Board tenure

The Board's policy on tenure is that the term the Chairman and other directors serve on the Board should not be restricted to a fi xed time limit.

The relevance of the individual length of service of the Chairman and other directors will be determined on a case by case basis. In addition to the length of service, consideration will be given to the contribution and ongoing independence of the individuals and the overall composition of the Board including the experience and range of skills of the Directors. By adopting a rounded approach, the Board believes it is best placed, through careful succession planning, to ensure that it has appropriate levels of experience and diversity whilst introducing new board members as needed.

In recent years the Board has successfully added new directors with complimentary skills through the appointments of Ashton Bradbury in May 2018 and Angela Henderson in October 2019. Summary biographies of all the directors can be found on page2 7.

Board succession

During the year the Board utilised Nurole, an online board recruitment platform, to assist in the recruitment of a new director. The search was successful, resulting in the recent appointment of Angela Henderson as an additional non-executive director. Arising from this process the Board also appointed Louise Page as a board observer.

Nurole has no other connection with the Company or individual directors, other than the inclusion of certain of the Company's directors on its database.

Board evaluation

The Directors recognise the importance of evaluating both the performance of the Board as a whole and that of individual directors.

The annual board evaluation is carried out by means of a questionnaire, this was updated during the year to ensure that it refl ected Code requirements. The evaluation questionnaire includes accountability and

effectiveness, culture, a directors' self-assessment and an appraisal of the Chairman.

The board evaluation was completed during the year and on review the Board is satisfi ed with the results and fi nds that the Board, the Chairman and the Directors are suitably qualifi ed to undertake their responsibilities and perform their duties in respect of managing the Company.

Diversity and inclusion

The Directors have a diverse range of experience, skills, length of service and backgrounds encompassing accounting and legal skills and experience of investing in both public and private companies. The Board has confi rmed that it will consider diversity when making future appointments and will always appoint the most appropriate person to ensure that the Board as a whole has an appropriate range of skills to successfully deliver its strategy. It will not discriminate on the grounds of gender, race, ethnicity, religion, sexual orientation, age or physical ability.

The Audit Committee

Information regarding the composition, responsibilities and activities of the Audit Committee are detailed in the report of the Audit Committee on pages 40 to 41.

Auditor's non-audit service

During the year no fees were paid for non-audit services (2018: £nil).

Risk and internal control

The directors acknowledge that they are responsible for the Company's systems of internal fi nancial and non-fi nancial controls. The controls are operating effectively and continue to be in place up to the date of this report. The key components of this process are as follows:

  • Day to day measures have been delegated to the investment manager, administrator and custodian. Written agreements are in place which defi ne the roles and responsibilities of these parties including the investment policy to be followed by the investment manager. The Board receives regular reports to provide it with assurance that appropriate oversight is in place. Additionally, the Board receives and reviews the annual internal control report published by its registrar.
  • On a quarterly basis the Board reviews the Company's management accounts, KPIs and investment reports provided by the administrator and manager.
  • Annual and half yearly reports and associated announcements are reviewed and approved by the Board prior to publication.
  • A detailed risk matrix is maintainedwhich identifi es each of the Company's principal risks, assesses the potential impact and describes the controls in place to mitigate those risks. A summary of the key risks can be found in the strategic report on page 14. The risk matrix is discussed regularly at board meetings, thereby ensuring that the nature and extent of the risks facing the Company are being actively monitored.
  • The Board reviews the Company's internal policies on an annual basis. The Board has also reviewed a summary of the range of risk management and internal controls it has in place to satisfy itself that the overall system of controls remains appropriate.

The Company does not have an internal audit function. All of the Company's management functions are performed by Hargreave Hale Limited and Canaccord Genuity Wealth Limited which have their own control systems in place. The Board receives regular reports to provide it with assurance that appropriate oversight is being applied and so has decided that it does not need its own internal audit function.

The Board considers that the control systems in place provide reasonable, but not absolute, assurance against material misstatement or loss, and to manage rather than eliminatethe risk of failure to achieve business objectives.

Remuneration

Due to the size of the Board, the Board has not established a separate remuneration committee and all remuneration responsibilities are therefore carried out by the Board. The Company's disclosure with regard to remuneration is included on page s 31 to 34.

Going concern

The Company's business activities and the factors affecting its future development are set out in the chairman's statement on pages 4 to 7 and the investment manager's report on pages 1 7 to 1 8. The Company's principal risks are set out in the strategic report on page 14.

The Board receives regular reports from the manager and administrator and reviews the fi nancial position, performance and liquidity of the Company's investment portfolio. Revenue forecasts and expense budgets are prepared at the start of each fi nancial year and performance against plan is reviewed by the Board. Cash forecasts are prepared and reviewed by the Board as part of the HMRC investment test compliance monitoring.

The Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for a period of at least twelve months. No material uncertainties related to events or conditions that may cast signifi cant doubt about the ability of the Company to continue as a going concern have been identifi ed by the Directors. For this reason, they continue to adopt the going concern basis in preparing the fi nancial statements.

Additional disclosures in the directors' report

Additional disclosures required by Schedule 7 of the Large and Medium sized Companies and Groups (Accounts and Reports) Regulations 2008 (as amended 2013) are contained in the directors' report on pages 2 8 to 30.

For and on behalf of the Board

Canaccord Genuity Wealth Limited Company Secretary

1 9 December 2019

Report of the Audit Committee

The Audit Committee consists of three independent non-executive directors at the year end - David Brock (Chairman), Sir Aubrey Brocklebank and Ashton Bradbury. Angela Henderson joined the Audit Committee at the meeting held on 4 December 2019. While the Chairman of the Board does not chair the Committee, he is a member, but the Board is of the opinion that this is appropriate because of his audit, accounting and tax expertise.

The Committee ordinarily meets twice a year . The Committee's terms of reference are available on the Company's website www.hargreaveaimvcts.co.uk and by request from the company secretary.

The main responsibilities of the Audit Committee are as follows:

  • To monitor the integrity of the Company's fi nancial statements including the interim reports, preliminary announcements and related formal statements before submission to and approval bythe Board . Paying particular attention to:
    • critical accounting policies and practices and any changes in them;
    • the clarity of disclosures;
    • compliance with accounting standards; and
    • compliance with stock exchange and other legal requirements.
  • To review the effectiveness of the Company's internal fi nancial control and risk management systems.
  • To consider and make recommendations to the Board on the appointment, reappointment and removal of the external auditor.
  • To assess the independence and objectivity of the external auditors and the effectiveness of the external audit process. The external auditor is not engaged to supply any non-audit services.

A summary of the Audit Committee's principal activities and key considerations for the year to 30 September 2019 is provided below.

Financial statements

The interim and annual reports to shareholders and the accounting policies therein were thoroughly reviewed by the Committee prior to submission to the Board for approval. The committee was of the view that the annual report and accounts, taken as a whole, is fair, balanced and understandable and provides the information necessary for shareholders to assess the Company's performance, business model and strategy.

The investment manager and the Company's auditor confi rmed to the Committee that they were not aware of any material misstatements to the fi nancial statements. Having reviewed the fi nancial statements and the report produced by the auditor, the Committee were satisfi ed that key areas of risks and judgement were appropriately addressed.

Risk and internal control

The Board has identifi ed the key risks faced by the Company and these are set out in the strategic report on page 14. The Committee (or the Board as a whole) has received and reviewed periodic reports to provide it with assurance that appropriate oversight of controls is in place at its key third party providers and to highlight instances of non-compliance.

The Committee has sought and obtained assurances from the investment manager that appropriate policies are in place to prevent bribery and corruption, and has received updates regarding cyber security initiatives. The Committee has reviewed the investment manager's whistleblowing policy and is satisfi ed that there are suffi cient arrangements in place for staff to raise concerns, in confi dence, about possible wrongdoing in fi nancial reporting or other matters.

The Board maintains a schedule of anti-fraud controls that is reviewed by the Committee and they are satisfi ed that the Board have suffi cient oversight and that adequate procedures are in place.

Key areas of risk

The key areas of risk identifi ed by the Audit Committee in relation to the business activities and fi nancial statements of the Company are as follows:

  • compliance with HM Revenue & Customs legislation to maintain the Company's VCT status;
  • valuation and existence of investments;
  • revenue recognition; and
  • management override of controls.

These issues were discussed with the auditor at the audit planning meeting and again at the Audit Committee meeting prior to the sign off of the fi nancial statements by the Board. The Committee concluded:

• Venture Capital Status. The investment manager confi rmed to the Audit Committee that the conditions for maintaining the Company's status had been complied with throughout the year. The Company's status is also reviewed by the Company's tax advisors Philip Hare & Associates LLP and further half yearly reconciliations are carried out. These reports are reviewed by the Board as a whole, which is happy with the reports produced.

  • Valuation and existence of investments. The investment manager has confi rmed to the Committee that the basis of valuation for investments was consistent with the prior year and in accordance with industry guidelines. The auditor confi rmed to the Committee that they had reviewed the estimates and judgements made by the investment manager when valuing the unlisted companies and that the valuations proposed were acceptable. They further confi rmed that there was no evidence of bias in the valuations of the investments based on the audit work performed. The Company's custodian CGWL provides the Company with quarterly reports confi rming that reconciliations to check the existence of the Company's investments have been carried out. Management accounts, including a full portfolio listing, are considered at quarterly board meetings.
  • Revenue recognition. The auditor confi rmed to the Audit Committee they have no adverse fi ndings to bring to the attention of the Committee.
  • Management override of controls. The auditors have confi rmed to the Audit Committee that, in respect of management override of controls and revenue recognition, they have no adverse fi ndings to report.

Relationship with the external auditor

The Committee is responsible for overseeing the relationship with the external auditor, assessing the effectiveness of the external audit process and making recommendations on the appointment and removal of the external auditor, including the level of audit fees and terms of engagement. The Committee meets with the external auditor as part of the audit process.

The Committee undertook a review of the auditor's performance during the 2019 audit and concluded that the auditor:

  • Provided a clear explanation of the audit plan, scope and strategy;
  • Met the agreed audit plan;
  • Was appropriately resourced with sound technical knowledge and demonstrated a clear understanding of the business;
  • Demonstrated a proactive approach to the planning process and engaged well with the Committee, Chairman and other key individuals within the business;
  • Responded to the Committee's questions and handled key audit issues effectively;
  • Demonstrated that it had appropriate procedures and safeguards in place to maintain its independence and objectivity; and
  • Charged justifi able fees in respect of the scope of services provided.

The Committee concluded that it is satisfi ed with the standard of service received and that the re-appointment of BDO LLP was in the best interest of the Company and its shareholders.

The Committee undertook a tender process in 2017 in line with mandatory audit tendering legislation. Rotation of the audit partner took place last year in accordance with the FRC's Ethical Standard for Auditors.

Subject to the Committee continuing to be satisfi ed with the performance of BDO LLP, the next statutory auditor rotation will take place in 2026, in line with legislative requirements for UK public entities.

Approved on behalf of the Board of Directors

David Brock Chairman of the Audit Committee

1 9 December 2019

Statement of directors' responsibilities

In respect of the fi nancial statements

The Directors are responsible for preparing the annual report and the fi nancial statements in accordance with applicable law and regulations. They are also responsible for ensuring that the annual report includes information required by the Listing Rules of the Financial Conduct Authority.

Company law requires the Directors to prepare fi nancial statements for each fi nancial year. Under that law the Directors are required to prepare the fi nancial statements and have elected to prepare the company fi nancial statements in accordance with United Kingdom Generally Accepted Accounting Practice ("UK GAAP") (United Kingdom Accounting Standards and applicable law). Under company law, the Directors must not approve the fi nancial statements unless they are satisfi ed that they give a true and fair view of the state of affairs of the Company and of the profi t or loss for the Company for that period.

In preparing these fi nancial statements, the Directors are required to:

  • select suitable accounting policies and then apply them consistently;
  • make judgements and accounting estimates that are reasonable and prudent;
  • state whether they have been prepared in accordance with UK GAAP , subject to any material departures disclosed and explained in the fi nancial statements;
  • prepare the fi nancial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business; and
  • prepare a directors' report, a strategic report and directors' remuneration report which comply with the requirements of the Companies Act 2006.

The Directors are responsible for keeping adequate accounting records that are suffi cient to show and explain the Company's transactions, and disclose with reasonable accuracy at any time the fi nancial position of the Company, and enable them to ensure that the fi nancial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The Directors are responsible for ensuring that the annual report and accounts, taken as a whole, are fair, balanced and understandable, and provide the information necessary for shareholders to assess the Company's position and performance, business model and strategy.

Website publication

The Directors are responsible for ensuring the annual report and the fi nancial statements are made available on a website. Financial statements are published on the Company's website in accordance with legislation in the United Kingdom governing the preparation and dissemination of fi nancial statements, which may vary from legislation in other jurisdictions. The maintenance and integrity of the Company's website is the responsibility of the Directors. The Directors' responsibility also extends to the ongoing integrity of the fi nancial statements contained therein.

Directors' responsibility statement pursuant to DTR4

Sir Aubrey Brocklebank (Chairman), David Brock, Oliver Bedford, Ashton Bradbury and Angela Henderson, the Directors confi rm to the best of their knowledge that:

  • the fi nancial statements have been prepared in accordance with UK GAAP and give a true and fair view of the assets, liabilities, fi nancial position and profi t and loss of the Company
  • the annual report includes a fair review of the development and performance of the business and the fi nancial position of the Company, together with a description of the principal risks and uncertainties that it faces.

For and on behalf of the Board

Sir Aubrey Brocklebank Chairman

1 9 December 2019

3

Fertile ground for growth

Hargreave Hale AIM VCT / Annual Report and Accounts 2019 43

Financial statements

Independent Auditor's report To the members of Hargreave Hale AIM VCT plc

Opinion

We have audited the fi nancial statements of Hargreave Hale AIM VCT PLC (the "company") for the year ended 30 September 2019 which comprise the income statement, the balance sheet, the statement of changes in equity and the statement of cash fl ows and notes to the fi nancial statements, including a summary of signifi cant accounting policies. The fi nancial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the fi nancial statements:

  • give a true and fair view of the state of the company's affairs as at 30 September 2019 and of its loss for the year then ended;
  • have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
  • have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the fi nancial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the fi nancial statements in the UK, including the FRC's Ethical Standard as applied to listed public interest entities, and we have fulfi lled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is suffi cient and appropriate to provide a basis for our opinion.

Conclusions relating to principal risks, going concern and viability statement

We have nothing to report in respect of the following information in the annual report, in relation to which the ISAs (UK) require us to report to you whether we have anything material to add or draw attention to:

  • the disclosures in the annual report set out on page 14 that describes the principal risks and explain how they are being managed or mitigated;
  • the directors' confi rmation set out on pages 40 in the annual report that they have carried out a robust assessment of the principal risks facing the company, including those that would threaten its business model, future performance, solvency or liquidity;
  • the directors' statement set out on page 39 in the fi nancial statements about whether the directors considered it appropriate to adopt the going concern basis of accounting in preparing the fi nancial statements and the directors' identifi cation of any material uncertainties to the company's ability to continue to do so over a period of at least twelve months from the date of approval of the fi nancial statements;
  • whether the directors' statement relating to going concern required under the Listing Rules in accordance with Listing Rule 9.8.6R(3) is materially inconsistent with our knowledge obtained in the audit; or
  • the directors' explanation in the annual report as to how they have assessed the prospects of the company, over what period they have done so and why they consider that period to be appropriate, and their statement as to whether they have a reasonable expectation that the company will be able to continue in operation and meet its liabilities as they fall due over the period of their assessment, including any related disclosures drawing attention to any necessary qualifi cations or assumptions.

Key audit matters

Key audit matters are those matters that, in our professional judgement, were of most signifi cance in our audit of the fi nancial statements of the current period and include the most signifi cant assessed risks of material misstatement (whether or not due to fraud) that we identifi ed, including those which had the greatest effect on: the overall audit strategy, the allocation of resources in the audit; and directing the efforts of the engagement team. These matters were addressed in the context of our audit of the fi nancial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

Key Audit Matter How we addressed the Key Audit Matter in the Audit

Valuation of investments (Notes 1 and 7 to the fi nancial statements)

The company's investments held at fair value through profi t and loss total £119,947k, of which £106,087k (88%) are valued using market bid price (level 1) and £13,860k (12%) are valued using more subjective techniques (level 3). Investments represent the most signifi cant balance in the fi nancial statements and are the primary driver of returns to shareholders.

There is a high level of estimation uncertainty involved in determining the unquoted investment valuations

Furthermore, the Investment Manager's fee is based on the value of the net assets of the fund, as shown in note 3. As the Investment Manager is responsible for valuing investments for the fi nancial statements, there is a potential risk of overstatement of investment valuations.

We tested 100% of the valuation of quoted investments by obtaining independently sourced market bid prices and comparing to the valuation recorded in the fi nancial statements.

We tested 99% of the level 3 unquoted investment portfolio at year-end by value of investment holdings.

As part of our detailed testing for such investments we:

  • Formed a determination of whether the valuation methodology is the most appropriate in the circumstances under the International Private Equity and Venture Capital Valuation Guidelines
  • Re-performed the calculation of investment valuations
  • Verifi ed and benchmarked key inputs in the valuation to independent information
  • Obtained the most recent audited accounts and most recent management accounts of the underlying investee company and considered the consistency of reported performance with the assumptions used in the valuations
  • Challenged the assumptions inherent in the valuation of unquoted investments by developing our own point estimates where alternative assumptions could reasonably be applied and considered the overall impact of such sensitisations on the portfolio of investments in determining whether the valuations as a whole are reasonable and free from bias.

Key Observations: Based on the procedures performed we concluded that the valuation of the portfolio of investments was not materially misstated.

Our application of materiality

We apply the concept of materiality both in planning and performing our audit, and in evaluating the effect of misstatements. We consider materiality to be the magnitude by which misstatements, including omissions, could infl uence the economic decisions of reasonable users that are taken on the basis of the fi nancial statements. In order to reduce to an appropriately low level the probability that any misstatements exceed materiality we use a lower materiality level, performance materiality, to determine the extent of testing needed. Importantly, misstatements below these levels will not necessarily be evaluated as immaterial as we also take account of the nature of identifi ed misstatements, and the particular circumstances of their occurrence, when evaluating their effect on the fi nancial statements. The application of these key considerations gives rise to three levels of materiality, the quantum and purpose of which are tabulated below.

Materiality
measure
Purpose Key considerations and
benchmarks
Quantum (£)
Financial
statement
materiality
Assessing whether the fi nancial
statements as a whole present a
true and fair view.
• The value of gross investments
• The level of judgement inherent
in the valuation
£1,200,000
(30 September
2018:
(1% of gross
investments)
• The range of reasonable
alternative valuations
£1,300,000)
Materiality
measure
Purpose Key considerations and
benchmarks
Quantum (£)
Performance
materiality
(75% of materiality)
Lower level of materiality applied in
performance of the audit when
determining the nature and extent
of testing applied to individual
balances and classes of
transactions.
• Financial statement materiality
• Risk and control environment
• History of prior errors (if any)
£900,000
(30 September
2018:
£975,000)
Specifi c
materiality
– classes of
transactions and
balances which
impact on net
realised returns
(10% gross
expenditure)
Assessing those classes of
transactions, balances or
disclosures for which misstatements
of lesser amounts than materiality
for the fi nancial statements as a
whole could reasonably be expected
to infl uence the economic decisions
of users taken on the basis of the
fi nancial statements.
• Level of gross expenditure £300,000
(30 September
2018:
£240,000)

We agreed with the Audit Committee that we would report to the Committee all audit differences in excess of 14,000 (2018 – £13,000), as well as differences below that threshold that, in our view, warranted reporting on qualitative grounds.

An overview of the scope of our audit

Our audit approach was risk based, and was developed by obtaining an understanding of the company's activities, and the overall control environment. Based on this understanding we assessed those aspects of the company's transactions and balances which were most likely to give rise to a material misstatement.

As part of designing our audit, we determined materiality and assessed the risks of material misstatement in the fi nancial statements. In particular, we looked at where the directors made subjective judgements, for example in respect of the valuation of investments which have a high level of estimation uncertainty involved in determining the unquoted investment valuations.

How the audit was considered capable of detecting irregularities, including fraud

We gained an understanding of the legal and regulatory framework applicable to the company and the industry in which it operates, and considered the risk of acts by the company which were contrary to applicable laws and regulations, including fraud. These included but were not limited to compliance with Companies Act 2006, the FCA listing and DTR rules, the principles of the UK Corporate Governance Code, industry practice represented by the SORP and FRS 102. We also considered the company's qualifi cation as a VCT under UK tax legislation as any breach of this would lead to the company losing various deductions and exemptions from corporation tax.

We designed audit procedures to respond to the risk, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion.

We focused on laws and regulations that could give rise to a material misstatement in the company fi nancial statements. Our tests included, but were not limited to:

  • agreement of the fi nancial statement disclosures to underlying supporting documentation;
  • enquiries of management;
  • review of minutes of board meetings throughout the period; and
  • obtaining an understanding of the control environment in monitoring compliance with laws and regulations

There are inherent limitations in the audit procedures described above and the further removed noncompliance with laws and regulations is from the events and transactions refl ected in the fi nancial statements, the less likely we would become aware of it. As in all of our audits we also addressed the risk of management override of internal controls, including testing journals and evaluating whether there was evidence of bias by the directors that represented a risk of material misstatement due to fraud.

Other information

The directors are responsible for the other information. The other information comprises the information included in the Annual Report and Financial Statements other than the fi nancial statements and our auditor's report thereon. Our opinion on the fi nancial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the fi nancial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the fi nancial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the fi nancial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

In this context, we also have nothing to report in regard to our responsibility to specifi cally address the following items in the other information and to report as uncorrected material misstatements of the other information where we conclude that those items meet the following conditions:

  • Fair, balanced and understandable set out on page 40 – the statement given by the directors that they consider the annual report and fi nancial statements taken as a whole is fair, balanced and understandable and provides the information necessary for shareholders to assess the company's performance, business model and strategy, is materially inconsistent with our knowledge obtained in the audit; or
  • Audit Committee reporting set out on page 40 the section describing the work of the audit committee does not appropriately address matters communicated by us to the audit committee; or
  • Directors' statement of compliance with the UK Corporate Governance Code set out on page 35 – the parts of the directors' statement required under the Listing Rules relating to the company's compliance with the UK Corporate Governance Code containing provisions specifi ed for review by the auditor in accordance with Listing Rule 9.8.10R(2) do not properly disclose a departure from a relevant provision of the UK Corporate Governance Code.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, the part of the directors' remuneration report to be audited has been properly prepared in accordance with the Companies Act 2006.

In our opinion, based on the work undertaken in the course of the audit:

  • the information given in the strategic report and the directors' report for the fi nancial year for which the fi nancial statements are prepared is consistent with the fi nancial statements; and
  • the strategic report and directors' report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identifi ed material misstatements in the strategic report or the directors' report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

  • adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
  • the fi nancial statements and the part of the directors' remuneration report to be audited are not in agreement with the accounting records and returns; or
  • certain disclosures of directors' remuneration specifi ed by law are not made; or
  • we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of directors' responsibilities, the directors are responsible for the preparation of the fi nancial statements and for being satisfi ed that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of fi nancial statements that are free from material misstatement, whether due to fraud or error.

In preparing the fi nancial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the fi nancial statements

Our objectives are to obtain reasonable assurance about whether the fi nancial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to infl uence the economic decisions of users taken on the basis of these fi nancial statements.

A further description of our responsibilities for the audit of the fi nancial statements is located on the Financial Reporting Council's website at:

www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Other matters which we are required to address

Following the recommendation of the Audit Committee, we were appointed by the Board of Directors to audit the fi nancial statements for the year ended 30 September 2007 and subsequent fi nancial periods. We were re-appointed as auditors in respect of the year ended 30 September 2019 by members of the company at the annual general meeting held on 6 February 2019. The period of total uninterrupted engagement, including retenders and reappointments, is 13 years, covering the year ending 30 September 2007 to 30 September 2019.

The non-audit services prohibited by the FRC's Ethical Standard were not provided to the company and we remain independent of the company in conducting our audit.

Our audit opinion is consistent with the additional report to the audit committee.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Peter Smith

(Senior Statutory Auditor) For and on behalf of BDO LLP, Statutory Auditor London United Kingdom

1 9 December 2019

BDO LLP is a limited liability partnership registered in England and Wales (with registered number OC305127).

Income statement

Year to 30 September 2019
Year to 30 September 2018
Note Revenue
£000
Capital
£000
Total
£000
Revenue
£000
Capital
£000
Total
£000
Net (loss)/gain on investments
held at fair value through profi t
or loss 7 (20, 687) (20, 687) 16,519 16,519
Income 2 1,163 354 1,517 806 78 884
1,163 (20, 333) (19, 170) 806 16,597 17,403
Management fee 3 (565) (1,696) (2,261) (416) (1,249) (1,665)
Other expenses 4 (6 16 ) ( 133 ) (74 9) (633) (109) (742)
(1, 181 ) (1, 829 ) (3,0 10) (1,049) (1,358) (2,407)
(Loss)/gainon ordinary activities
before taxation
( 18 ) (22,1 62 ) (22, 180) (243) 15,239 14,996
Taxation 5
(Loss)/gainafter taxation ( 18 ) (22,1 62 ) (22, 180) (243) 15,239 14,996
(Loss)/gainper share basic and
diluted
6 (0.0 1 ) (11.0 4 ) (11. 05) (0.19) 11.81 11.62

The total column of these statements is the income statement of the Company. All revenue and capital items in the above statements derive from continuing operations. There was no other comprehensive income other than the loss/ gainfor the year.

The accompanying notes are an integral part of these fi nancial statements.

Balance sheet As at 30 September 2019

Company Registration Number 5206425 (In England and Wales)

Note 2019
£000
2018
£000
Fixed assets
Investments at fair value through profi t or loss
7
1 19,947 130,105
Current assets
Debtors
9
466 167
Cash at bank 24,638 24,860
2 5,104 25,027
Creditors: amounts falling due within one year
1 0
(1,009) (346)
Net current assets 2 4,095 24,681
Total assets less current liabilities 14 4,042 154,786
Capital and Reserves
Called up share capital
1 1
2,040 1,767
Share premium 24,238
Capital redemption reserve 46 5
Special reserve 112,803 125,919
Capital reserve – realised ( 16,043 ) (2,774)
Capital reserve – unrealised 21, 713 30,606
Revenue reserve ( 755 ) (737)
Total shareholders' funds 14 4,042 154,786
Net asset value per share (basic and diluted)
1 2
70. 60p 87.59p

These fi nancial statements were approved and authorised for issue by the Board of Directors on 1 9 December 2019 and signed on its behalf by

Sir Aubrey Brocklebank Chairman

1 9 December 2019

The accompanying notes are an integral part of these fi nancial statements.

Statement of changes in equity

For the year ending 30 September 2019

Non-distributable reserves Distributable reserves(1)
Note Share
Capital
£000
Share
Premium
£000
Capital
Redemption
Reserve
£000
Capital
Reserve
Unrealised
£000
Special
Reserve
£000
Capital
Reserve
Realised
£000
Revenue
Reserve
£000
Total
£000
At 1 October 2018 1,767 5 30,606 125,919 (2,774) (737) 154,786
Share buybacks 1 1 (41) 41 (2,902) (2,902)
Share Issues 1 1 314 24,686 25,000
Issue Costs 1 1 (448) (448)
Equity dividends paid 16 (10,214) (10,214)
Permanent impairment 10,651 (10,651)
Realised losses on
investments
7 ( 1,14 3) ( 1,14 3)
Unrealised losses on
investments
7 ( 19, 544) ( 19, 544)
Management fee charged
to capital
3 (1,696) (1,696)
Income allocated to capital 2 354 354
Due diligence investments
costs
4 ( 133 ) ( 133 )
Revenue loss after taxation
for the year
( 18 ) ( 18 )
Total loss after taxation ( 19, 544) ( 2, 618 ) ( 18 ) (22, 180)
At 30 September 2019 2,040 24,238 46 21, 713 112,803 (1 6,043 ) ( 755 ) 144 ,042

Reserves available for distribution are capital reserve realised, special reserve and revenue reserve. Total distributable reserves at 30 September 2019 were £96.0 million. The accompanying notes are an integral part of these fi nancial statements.

(1) The Income Taxes Act 2007 restricts distribution of capital from reserves created by the conversion of the share premium account into a special (distributable) reserve until the third anniversary of the share allotment that led to the creation of that part of the share premium account. As at 30 September 2019, £70.8 million of the special reserve is subject to this restriction.

Statement of changes in equity

For the year ending 30 September 2018

Non-distributable reserves Distributable reserves(1)
Note Share
Capital
£000
Share
Premium
£000
Capital
Redemption
Reserve
£000
Capital
Reserve
Unrealised
£000
Special
Reserve
£000
Capital
Reserve
Realised
£000
Revenue
Reserve
£000
Total
£000
At 1 October 2017 816 37,515 37 17,237 15,522 (4,644) (494) 65,989
Share buybacks 1 1 (29) 29 (2,387) (2,387)
Share Issues 1 1 293 24,707 25,000
Issue Costs 1 1 (499) (499)
Acquisition of Hargreave
Hale AIM VCT 2 plc
687 55,919 56,606
Capital Reduction (117,642) (61) – 117,703
Equity dividends paid 16 (4,919) (4,919)
Realised gains on
investments
7 3,150 3,150
Unrealised gains on
investments
7 13,369 13,369
Management fee charged
to capital
3 (1,249) (1,249)
Income allocated to capital 2 78 78
Due diligence investments
costs
4 (109) (109)
Revenue loss after taxation
for the year
(243) (243)
Total gain/(loss) after
taxation
13,369 1,870 (243) 14,996
At 30 September 2018 1,767 5 30,606 125,919 (2,774) (737) 154,786

Reserves available for distribution are capital reserve realised, special reserve and revenue reserve. Total distributable reserves at 30 September 2018 were £122.4 million. The accompanying notes are an integral part of these fi nancial statements.

(1) The Income Taxes Act 2007 restricts distribution of capital from reserves created by the conversion of the share premium account into a special (distributable) reserve until the third anniversary of the share allotment that led to the creation of that part of the share premium account. As at 30 September 2018, £80.8 million of the special reserve is subject to this restriction.

Statement of cash fl ows

Note 2019
£000
2018
£000
Total loss on ordinary activities before taxation (22, 180) 14,996
Realised loss/(gain) on investments
7
1,14 3 (3,150)
Unrealised loss/(gain) on investments
7
19, 544 (13,369)
Decrease/(Increase) in debtors (299) (104)
Increase in creditors 663 140
Non-cash distributions
2
(16 6)
Net cash (outfl ow) from operating activities ( 1,295) (1,487)
Purchase of investments
7
(35, 628) (18,487)
Sale of investments
7
25,265 13,016
Net cash used in investment activities (10, 363) (5,471)
Share buybacks
11
(2,902) (2,387)
Issue of share capital
11
25,000 25,000
Issue costs
11
(448) (499)
Cash acquired on acquisition of Hargreave Hale AIM VCT 2 plc 6,616
Dividends paid
16
(10,214) (4,919)
Net cash provided by fi nancing activities 11,436 23,811
Net increase/(decreased) in cash (222) 16,853
Opening cash 24,860 8,007
Closing cash 24,638 24,860

The accompanying notes are an integral part of these fi nancial statements.

Notes to the fi nancial statements As at 30 September 2019

Hargreave Hale AIM VCT plc is a company incorporated in England and Wales under the Companies Act. The address of the registered offi ce is given in the company information on page 7 1 and the nature and principal business activities are set out in the strategic report.

1. Accounting policies

A summary of the principal accounting policies, all of which have been applied consistently throughout the year, is set out below:

Basis of preparation

The fi nancial statements have been prepared in accordance with UK Generally Accepted Accounting Practice ("UK GAAP"), including Financial Reporting Standard 102 ("FRS 102") and with the Companies Act 2006 and the Statement of Recommended Practice for "Financial Statements of Investment Trust Companies and Venture Capital Trusts" October 2019 ("SORP").

Financial instruments

All investments are classifi ed as fair value through profi t or loss. Investments are measured initially and subsequently at fair value which is deemed to be market bid prices for listed investments and investments traded on AIM. Unquoted investments are valued using the most appropriate methodology recommended by the International Private Equity Venture Capital ("IPEV") guidelines published in December 2018.

Where no active market exists for the particular asset, the Company holds the investment at fair value as determined by the investment manager and approved by the Board. Valuations of unquoted investments are reviewed on a quarterly basis and more frequently if events occur that could have a material impact on the investment.

In estimating fair value for an unquoted investment, the investment manager will apply one or more valuation techniques according to the nature, facts and circumstances of the investment. The investment manager will use reasonable current market data and inputs combined with market participant assumptions. The assessment of fair value will refl ect the market conditions at the measurement date irrespective of which valuation technique is used. The IPEV guidelines describe a range of valuation techniques, including but not limited to relevant observable market multiples, independent arms-length transactions, income, discounted cash fl ows and net assets.

Investments are recognised and derecognised at trade date where a purchase or sale is under a contract whose terms require delivery within the time frame established by the market concerned. Purchases and sales of unlisted investments are recognised when the contract for acquisition or sale becomes unconditional. Transaction costs are included in the initial cost or deducted from the disposal proceeds as appropriate.

These investments will be managed and their performance evaluated on a fair value basis in accordance with a documented investment strategy and information about them is provided internally on that basis to the Board.

Gains and losses arising from changes in fair value (realised and unrealised) are included in the net profi t or loss for the period as a capital item in the income statement and are taken to the unrealised capital reserve or realised capital reserve as appropriate.

If an investment has been impaired such that there is no realistic expectation that there will be a full return from the investment, the loss is treated as a permanent impairment and transferred to the capital reserve realised.

Other fi nancial assets and liabilities comprise receivables, payables and cash which are measured at amortised cost. There are no fi nancial liabilities other than payables.

Acquisition accounting

Where the assets and liabilities of another VCT are acquired by the Company through a business combination the identifi able assets and liabilities are initially recognised at their fair values at the acquisition date.

Income

Equity dividends are taken into account on the ex-dividend date, net of any associated tax credit. Fixed returns on nonequity shares and debt securities are recognised on a time apportionment basis so as to refl ect the effective yield, provided there is no reasonable doubt that payment will be received in due course. All other income is recognised on an accruals basis. Other income is treated as a repayment of capital or revenue depending on the facts of each particular case.

Expenditure

All expenditure is accounted for on an accruals basis. Of investment management fees, 75% are allocated to the capital reserve realised and 25% to the revenue account in line with the Board's expected long term split of investment returns in the form of capital gains to the capital column of the income statement. Due diligence costs incurred for prospective private company purchases are charged to capital in addition to the cost of investment. All other expenditure is charged to the revenue account.

Trail commission

Trail commission previously due is held as a creditor until such time as claims are made by the relevant intermediary and supporting documentation provided. If claims are not received these amounts are written off after a period of six years.

Capital reserves

Realised profi ts and losses on the disposal of investments, due diligence costs, income that is capital in nature, losses realised on investments considered to be permanently

impaired and 75% of investment management fees are accounted for in the capital reserve realised.

Increases and decreases in the valuation of investments held at the year end are accounted for in the capital reserve unrealised.

Operating segments

There is considered to be one operating segment being investment in equity and debt securities.

Taxation

Deferred tax is recognised in respect of all timing differences that have originated but not yet reversed at the balance sheet date. Deferred tax assets are only recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profi ts.

Current tax is expected tax payable on the taxable profi t for the period using the current tax rate and laws that have been enacted or substantially enacted at the reporting date. The tax effect of different items of income and expenditure is allocated between capital and revenue on the same basis as the particular item to which it relates.

Approved VCTs are exempt from tax on capital gains from the sale of fi xed asset investments. The Directors intend that the Company will continue to conduct its affairs to maintain its VCT status, no deferred tax has been provided in respect of any capital gains or losses arising from the revaluation or disposal of investments.

Dividends

Only dividends recognised during the year are deducted from revenue or capital reserves. Equity dividends are recognised in the accounts when they become legally payable.

Interim dividends are approved by the Board of Directors and may be varied or rescinded at any time before payment, therefore the liability is only established when the dividend is actually paid. Final dividends are subject to approval at the AGM. When the dividend is declared it states that it is payable on a future date, so liability is established on that date.

Functional currency

In accordance with FRS 102 s.30, the Company is required to nominate a functional currency, being the currency in which the Company predominantly operates. The Board has determined that sterling is the Company's functional currency. Sterling is also the currency in which these accounts are presented.

Repurchase of shares to hold in treasury

The cost of repurchasing shares into treasury, including the related stamp duty and transaction costs is charged to the special reserve and dealt with in the statement of changes in equity. Share repurchase transactions are accounted

for on a trade date basis. Where shares held in treasury are subsequently cancelled, the nominal value of those shares is transferred out of share capital and into capital redemption reserve.

Should shares held in treasury be reissued, the sale proceeds will be treated as a realised profi t up to the amount of the purchase price of those shares and will be transferred to capital reserves. The excess of the sale proceeds over the purchase price will be transferred to share premium.

Capital structure

Share Capital

Ordinary shares are classed as equity. The ordinary shares in issue have a nominal value of one pence and carry one vote each. Substantial holdings in the Company are disclosed in the directors' report on page 2 8.

Share Premium

This reserve represents the difference between the issue price of shares and the nominal value of shares at the date of issue, net of related issue costs.

Capital Redemption Reserve

This reserve is used for the cancellation of shares bought back under the buyback facility.

Special Reserve

Distributable reserve used to pay dividends and repurchase shares under the buyback facility.

Capital Reserve Realised

Gains/losses on disposal of investments, due diligence costs, income that is capital in nature, permanent impairment of fi nancial assets and 75% of the investment management fee are accounted for in the capital reserve realised.

Capital Reserve Unrealised

Unrealised gains and losses on investments held at the year end arising from movements in fair value are taken to the capital reserve unrealised.

Revenue Reserve

Net revenue profi ts and losses of the Company.

Key judgements and estimates

The preparation of the fi nancial statements requires the Board to make judgements and estimates that affect the application of policies and reported amounts of assets, liabilities, income and expenses. Key estimation uncertainties mainly relate to the fair valuation of unquoted investments.

The assessment of fair value will refl ect the market conditions at the measurement date irrespective of which valuation technique is used.

The IPEV guidelines describe a range of valuation techniques, as described in the "Financial instruments" section on page 54.

The estimates are under continuous review with particular attention paid to the carrying value of the investments. The process of estimation is also affected by the determination of fair value hierarchy described in note 7 to the fi nancial statements.

2. Income

2019
£000
2018
£000
Income from investments:
Revenue:
UK dividends 1,093 793
Unfranked investment income 13 13
Interest 57
1,163 806
Capital:
Arrangement fees 22
Return of capital 18 8(1) 56
In-specie dividend 16 6(2)
354 78
Total Income 1,517 884

(1) Distribution from Micro Focus plc relating to the completion of the disposal of the SUSE business. Distribution from Cineworld plc relating to the sale and leaseback transaction of 18 US based multi-screen cinemas.

(2) The Company received shares in Renalytix plc as a result of an in-specie dividend from EKF Diagnostics Holdings plc. This has been treated as capital income.

3. Management fees

2019
Revenue
£000
2019
Capital
£000
2019
Total
£000
2019
Revenue
£000
2019
Capital
£000
2019
Total
£000
Management fees 565 1,696 2,261 416 1,249 1,665
Total 565 1,696 2,261 416 1,249 1,665

2019 2019 2019 2018 2018 2018

The investment management agreement terminates on 12 months' notice, subject to earlier termination in certain circumstances. In the event of termination by the Company on less than the agreed notice period, compensation may be payable to the investment manager in lieu of the unexpired notice period. No notice had been given by the investment manager or by the Board to terminate the agreement as at the date of approval of these accounts.

The investment manager receives an investment management fee of 1.7% per annum of the NAV of the Company (effective from 1 April 2019, previously 1.5%), calculated and payable quarterly in arrears. At 30 September 2019, £807,251 (2018: £186,504) was owed in respect of management fees. The Company receives a reduction to the annual management fee for investments in other funds managed by Hargreave Hale Limited, being its investment in the Marlborough Special Situations Fund so the Company is not charged twice for these services. This amounted to £54,385 for the year to 30 September 2019 (2018: £37,800). Hargreave Hale Limited has agreed to indemnify the Company against annual running costs exceeding 3.5% of its net assets. No fees were waived between 1 October 2018 and 30 September 2019 and no fees were waived between 1 October 2017 and 30 September 2018 under the indemnity.

4. Other expenses

2019
£000
2018
£000
Other revenue expenses:
Administration fee 133 92
Directors' fees 77 87
Legal & professional 43 75
Registrar's fee 43 72
Printing, postage and stationery 32 28
Auditors' remuneration – for audit services 24 26
VCT monitoring fees 17 19
Company Secretarial fees 17 24
Custody fee 20 11
Directors' and offi cers' liability insurance 13 6
Broker's fee 5 5
Trail commission (7) (24)
VAT 79 92
Other expenses(1) 120 120
Total other revenue expenses 616 633
Other capital expenses:
Due diligence costs 111 31
VAT on due diligence costs 22 6
Stamp Duty 72
Total other capital expenses 133 109
Total other expenses 74 9 742

(1) Other expenses include London Stock Exchange fees, FCA fees, AIC membership fees, license and advertising costs and other nominal expenses.

Only directors are classifi ed as key management personnel. The Directors' remuneration above includes national insurance contributions. Directors' remuneration excluding employer's national insurance contributions is detailed in the directors' remuneration report on page 3 3.

The maximum aggregate directors' emoluments authorised by the Articles of Association are detailed in the directors' remuneration report on page 31.

5. Tax on ordinary activities

The tax charge for the year is based on the standard rate of UK Corporation Tax of 19%.

2019
Total
£000
2018
Total
£000
(Loss)/profi t on ordinary activities before taxation (22, 180) 14,996
UK Corporation Tax: 19% (4,2 14) 2,849
Effect of non taxable losses/(profi ts) on investments 3,9 31 (3,139)
Effect of non taxable UK dividend income (275) (161)
Effect of current year losses carried forward 558 451
Current tax charge

At the 30 September 2019 the Company had tax losses carried forward of £10,360, 586 (2018: £7,426,668 – prior year updated). It is unlikely that the Company will generate enough taxable income in the future to use these expenses to reduce future tax charges and therefore no deferred tax asset has been recognised.

There is no taxation charge in relation to capital gains or losses. No asset or liability has been recognised in relation to capital gains or losses on revaluing investments. The Company is exempt from such tax as a result of its intention to maintain its status as a Venture Capital Trust.

6. Earnings per share

2019
Revenue
2019
Capital
2019
Total
2018
Revenue
2018
Capital
2018
Total
Return (£) ( 18,218 ) (22,1 62,255 ) (22, 180,473) (242,791) 15,239,153 14,996,362
(Loss)/profi t per ordinary
share (basic and diluted)
(0.0 1 )p (11.0 4 )p (11. 05)p (0.19)p 11.81p 11.62p

The earning per share is based on 200,668,966 Ordinary shares (2018: 129,091,888), being the weighted average number of shares in issue during the year.

7. Investments

Quoted
investments
2019
£000
Unquoted
investments(1)
2019
£000
Total
investments
2019
£000
Total
investments
2018
£000
Opening Valuation 103,043 27,062 130,105 58,125
Purchases at cost 30,133 5, 559 35, 692(3) 18,487
Purchases through acquisition 49,990
Re-classifi cation adjustment (121 )
(2)
57 (2) (64)(2)
In-specie dividend 16 6 16 6
Sale proceeds (21,903) (3,362) (25,265) (13,016)
Realised (losses)/gains (1, 299) 156 (1,14 3) 3,150
Unrealised (losses)/gains (15,372 ) (4, 172 ) (19, 544) 13,369
Closing valuation 94,647 25, 300 1 19,947 130,105
Cost at 30 September 2019 81, 2 13 27, 6 72 10 8,885 99,842
Unrealised (losses)/gains at 30 September 2019 19, 2 64 2,4 49 21, 713 30,263
Permanent impairment at 30 September 2019(4) (5,830) (4,821) (10,651)
Valuation at 30 September 2019 94,647 25, 300 1 19,947 130,105

(1) Includes £11.4 million in 2019 and £13.9 million in 2018 invested in the Marlborough Special Situations Fund.

(2) Includes c ommission rebate from investment manager (£64k) – that reduces the purchase cost of impacted stocks. Additional adjustment for Paragon Entertainment Ltd that was delisted on 25 June 2019.

  • (3) Including £12. 0 million invested into Qualifying Companies, further information can be found in the investment manager's report on pages 1 7 to 18.
  • (4) Permanent impairments were made in the year amounting to £10,651,351.

Transaction Costs

During the year the Company incurred transaction costs of £133,214 and £39,951 on purchases and sales respectively. These amounts are included in the gain/(loss) on investments as disclosed in the income statement.

Fair Value Measurement Hierarchy

The table below sets out fair value measurements using FRS102 (appendix to section 2 fair value measurement) fair value hierarchy. The Company has one class of assets, being at fair value through profi t or loss.

  • Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities
  • Level 2: Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices)
  • Level 3: Valued by reference to valuation techniques using inputs that are not based on observable market data.

The following table sets out the basis of valuation for the Level 3 investments held within the portfolio at 30 September 2019.

Level 3 Unquoted Investments
Mexican Grill Ltd The fair value of the investment has been increased to £71.05 per share based on
rolling forward the September 2018 multiple by 12 months. EV/EBITDA peer group
ratios were analysed and a discounted cashfl ow analysis calculation were completed
to support the valuation.
Portr Ltd The fair value of the investment was written down to £1.00 per share refl ecting
downgrades in forecasts and funding risk.
Laundrapp Ltd The fair value of the investment was written down to £1.25 per share refl ecting
downgrades in forecast. The share price also refl ects the price of the most recent
transaction in the shares (on an arm's length basis).
Honest Brew Ltd The fair value of the investment has been marked down to £0.0 4 per share refl ecting
material downgrades in forecasts and funding risk.
SCA Investments Ltd (G ousto) The fair value of the investment has been increased to £67.38 per share based on
rolling forward the September 2018 multiple by 12 months. EV/Sales peer group
ratios were analysed to support the valuation. The share price also refl ects the price
of the most recent transaction in the shares (on an arm's length basis).
Zappar Ltd Fair value of investment is maintained at £74.45 per share, our entry price. The
valuation was tested against listed peers and discounted cash fl ow analysis.
Infi nity Reliance Ltd
(My 1st Years)
The fair value of the investment has been marked down to £28.68, refl ecting weak
performance and downgrades to 2019 and 2020 forecasts. The valuation has been
tested against peer EV/Sales ratios.
Oxford Genetics The fair value of the investment has been maintained at £320.00 per share, our
entry price. The valuation was tested against listed peers.
2019 2019
2019
2019
2018
2018
2018
2018
2019 2019 2019 2019 2018 2018 2018 2018
Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total
£000 £000 £000 £000 £000 £000 £000 £000
Investments 106,087 13,860 1 19,947 116,907 13,198 130,105

8. Signifi cant interests

At the year end the Company held 3% or more of the issued share capital of the following investments:

Investment Holding % Investment Holding %
Honest Brew Ltd 32.88% Zoo Digital Group plc 6.20%
Laundrapp Ltd 17.45% Surface Transforms plc 5.66%
Location Sciences Group plc 12.95% Blackbird plc 5.26%
Escape Hunt plc 11.34% PCI-PAL plc 4.68%
Hardide plc 10.41% Osirium Technologies plc 4.49%
Infi nity Reliance Ltd (My 1st Years) 8.97% Clearstar Inc 3.90%
Mexican Grill Ltd 7.72% Gfi nity plc 3.84%
Portr Ltd 7.17% KRM22 plc 3.78%
Oxford Genetics Ltd 7.17% Beeks Financial Cloud Group plc 3.72%
Zappar Ltd 6.97% Cloudcall Group plc 3.49%
Crossword Cybersecurity plc 6.46% Eagle Eye Solutions Group plc 3.40%
Investment Holding %
Zoo Digital Group plc 6.20%
Surface Transforms plc 5.66%
Blackbird plc 5.26%
PCI-PAL plc 4.68%
Osirium Technologies plc 4.49%
Clearstar Inc 3.90%
Gfinity plc 3.84%
KRM22 plc 3.78%
Beeks Financial Cloud Group plc 3.72%
Cloudcall Group plc 3.49%
Eagle Eye Solutions Group plc 3.40%

9. Debtors

2019
£000
2018
£000
Prepayments and accrued income 466 167

10. Creditors: amounts falling due within one year

2019
£000
2018
£000
Trade Creditors 3 7
Accruals and deferred income 1,006 339
1,009 346

11. Called up share capital

2019
£000
2018
£000
Allotted, called-up and fully paid: 204,014,367
(2018: 176,711,020) ordinary shares of 1p each. 2,040 1,767

During the year 4,076,170 (2018: 2,959,394) ordinary shares were purchased through the buyback facility at a cost of £2,902,402 (2018: £2,387,356). The repurchased shares represent 2.3% (2018: 3.6%) of ordinary shares in issue on 1 October 2018. The acquired shares have been cancelled.

During the year, the Company issued 31,379,517 ordinary shares of 1 pence (nominal value £313,795) in an offer for subscription, representing 17. 7% of the opening share capital at prices ranging from 73.59p to 83.70p per share. Gross funds of £25,000,000 were received. The 3.5% premium of £875,000 payable to Hargreave Hale Limited under the terms of the offer was reduced by £426,670, being the discount awarded to investors in the form of additional shares. A further reduction of £150 introductory commission was made resulting in fees payable to Hargreave Hale Limited of £448,180 which were then used to pay other costs associated with the prospectus and marketing .

Further details of the Company's capital structure can be seen in note 1.

Income entitlement

The revenue earnings of the Company are available for distribution to holders of ordinary shares by way of interim, fi nal and special dividends (if any) as may from time to time be declared by the Directors.

Capital entitlement

The capital reserve realised and special reserve of the Company are available for distribution to holders of ordinary shares by way of interim, fi nal and special dividends (if any) as may from time to time be declared by the Directors.

Voting entitlement

Each ordinary shareholder is entitled to one vote on a show of hands and on a poll to one vote for each ordinary share held. Notices of meetings and proxy forms set out the deadlines for valid exercise of voting rights and other than with regard to directors not being permitted to vote on matters upon which they have an interest, there are no restrictions on the voting rights of ordinary shareholders.

Transfers

There are no restrictions on transfers except dealings by directors, persons discharging managerial responsibilities and their persons closely associated which may constitute insider dealing or is prohibited by the rules of the UKLA.

The Company is not aware of any agreements with or between shareholders which restrict the transfer of ordinary shares, or which would take effect or alter or terminate in the event of a change of control of the Company.

12. Net asset value per ordinary share

30 September
2019
30 September
2018
Net assets (£'000) 14 4,042 154,786
Shares in issue 204,014,367 176,711,020
NAV per share 70. 60 87.59

There are no potentially dilutive capital instruments in issue and as such, the basic and diluted NAV per share are identical.

13. Contingencies, guarantees and fi nancial commitments

There were no contingencies, guarantees or fi nancial commitments of the Company at the year end (2018: nil).

14. Related party transactions and confl icts

The remuneration of the directors, who are key management personnel of the Company, is disclosed in the Directors' remuneration report on page 33 and in note 4 on page 57.

David Brock was appointed as non-executive Chairman of Honest Brew Ltd on 25 July 2019 to assist with the delivery of its business plan.

Transactions with the manager

As the Company's investment manager, Hargreave Hale Limited is a related party to the Company for the purposes of the Listing Rules. As Hargreave Hale Limited and Canaccord Genuity Wealth Limited (CGWL) are part of the same CGWL group, CGWL also falls into the defi nition of related party.

Oliver Bedford, a non-executive director of the Company is also an employee of Hargreave Hale Limited wh ich received fees of £18,000 for the year ended 30 September 2019 in respect of his position on the Board (2018: £25,028 which includ ed a payment of £7,028 for his Hargreave Hale AIM VCT 2 plc directorship). Of these fees £7,500 was still owed at the year end.

From 1 October 2019, director s' fees increased to £25,000.

CGWL act as administrator and custodian to the Company and provide the company secretary. The Company has recently entered into a series of new agreements with CGWL. On 5 April 2019 the Company entered into a new custody agreement with CGWL. Under the terms of the new custody agreement the annual custody fee was increased from £10,000 to £30,000. On 25 June 2019, the Company entered into new administration and secretarial contracts with CGWL. Under the new agreements the annual fee for administration services increased from £110,000 to £195,000. The fee for secretarial services remains unchanged at £17,000.

CGWL received fees for the support functions as follows:

30 September
2019
30 September
2018
Custody 19,642 11,404(1)
Administration 132,713 91,667
Company secretarial 17,000 23,638(2)
Total 169,355 126,709
Still owed at the year end 88,130 22,833

(1) Includes £1,404 in relation to VCT 2 custody services

(2) Includes £6,638 in relation to VCT 2 company secretarial services

Investment management will continue to be provided by Hargreave Hale Limited under a new agreement which commenced on 25 June 2019. As previously disclosed , the annual fee payable to the investment manager increased to 1.7% with effect from 1 April 2019. The annual fee continues at this rate under the new agreement. The investment manager's previous entitlement to earn a performance fee has been removed under the updated arrangement.

Investment management fees for the year are £2,26 1,355 (2018: £1,665,754) as detailed in note 3. £807,251 was still owed at the year end in respect of investment management fees (2018: 186,504) .

A further £448,180 was paid to Hargreave Hale Limited under the terms of the offer agreement as detailed in note 11.

Total commission of £ 85,874 was paid to CGWL in the year for broker services.

Hargreave Hale Limited has agreed to indemnify the Company and keep indemnifi ed the Company in respect of the amount by which the annual running costs of the Company exceed 3.5%of the net assets of the Company, such costs shall exclude any VAT payable thereon and any payments to fi nancial intermediaries, the payment of which is the responsibility of the Company. No fees were wa ived by Hargreave Hale Limited in the fi nancial year under the indemnity.

The Company also held £14,362,793 in the client account held at CGWL at 30 September 2019.

15. Financial instruments

Risk management policies and procedures

The investment objective of the Company is to achieve long term capital growth and to maximise tax free distributions to shareholders by investing in a diversifi ed portfolio of small UK Qualifying Companies primarily trading on AIM. At least 70% of the Company's funds have been invested in qualifying holdings during the year under the HMRC investment test defi nition. The balance of the Company's funds were invested in liquid assets (such as non-qualifying equities, fi xed interest securities and bank deposits). The Company is managed as a VCT in order that shareholders in the Company may benefi t from the tax relief available.

This strategy exposes the Company to certain risks, which are summarised below.

The structure in place to manage these risks is set out in the corporate governance report on pages 3 5 to 3 9 of the annual report and accounts. The Board meets quarterly to review accounts and monitor all risks.

A detailed review of the investment portfolio is contained in the chairman's statement and investment manager's report on pages 4 to 7 and 1 7 to 1 8 respectively.

The investments at year end comprise one type of fi nancial instrument. The basis of valuation is set out below:

• Equities – fair value through the profi t and loss account.

Other fi nancial assets comprise cash at bank of £24,638,431 (2018: £24,860,177), accrued income and debtors of £151,814 (2018: £151,999), which is classifi ed as 'loans and receivables measured at amortised cost'. Financial liabilities consist of trade creditors and accruals of £1,009, 955 (2018: £345,873) which are classifi ed as 'fi nancial liabilities measured at amortised cost'.

Market risk

Market price risk arises from any fl uctuations in the value of investments held by the Company. Adherence to investment policies mitigates the risk of excessive exposure to any particular type of security or issuer. In particular, no more than 15% of the investment portfolio is invested in any one company. However, many of the investments are in small companies traded on the AIM market which by virtue of their size carry more risk than investments in larger companies listed on the main market of the London Stock Exchange.

Market risk is monitored by the Board on a quarterly basis and on an ongoing basis through the investment manager.

The following table summarises exposure to price risk by asset class at year end date:

2019
£000
2018
£000
Equity Fair value 108, 507 116,241
Authorised unit trust Fair value 11,440 13,864
Fixed income securities Fair value
1 19,947 130,105

If market prices had been 10% higher or lower while all other variables remained unchanged the return attributable to ordinary shareholders for the year ended 30 September 2019 would have increased/decreased by £1 1,994,700 (2018: £13,010,500). This is based on the Company's total equity portfolio including private company investments held at year end.

Currency risk

The Company is exposed to currency risk when disposing of investments in foreign currencies between the date the transaction was entered into and settlement. These transactions are made infrequently in order to minimise the impact of exposure.

Interest rate risk

The Company is fully funded through equity and has no debt, therefore interest rate risk is not considered a material risk.

The Company's fi nancial assets and liabilities are denominated in sterling as follows:

30 September 2019
Fixed
Rate
£000
Variable
Rate
£000
Non-Interest
Bearing
£000
Total
£000
Investments 1 19,947 1 19,947
Cash and cash equivalents 24,638 24,638
Other currents assets and current liabilities (net) ( 543) ( 543)
Net assets 24,638 119, 404 14 4,042
30 September 2018
Fixed
Rate
£000
Variable
Rate
£000
Non-Interest
Bearing
£000
Total
£000
Investments 130,105 130,105
Cash and cash equivalents 24,860 24,860
Other currents assets and current liabilities (net) (179) (179)
Net assets 24,860 129,926 154,786

Interest rate risk exposure relates to fi xed income securities and cash and cash equivalents (bank deposits) where interest income is primarily linked to bank base rates. Interest rate risk exposure on debt instruments is refl ected in the market risk and since these securities are valued at fair value, no additional disclosure is made in this respect. Movements in interest rates on cash and cash equivalents are not considered a material risk.

Liquidity risk

Liquidity risk is the risk that the Company is unable to meet obligations as they fall due. As the Company has no debt or other fi nancial liabilities other than trade creditors and accruals of £1,009, 955, liquidity risk is not considered material. As at 30 September 2019 the Company held £24,638,431 on bank deposit.

Credit risk

Credit risk relates to the risk of default by a counterparty. No assets are past due date for payment or impaired. There have been no changes in the fi nancial value of the Company during the year that are attributable to credit risk.

An asset is considered to be impaired in the case of investments if the investee company makes continued losses or defaults on payment.

The maximum credit risk exposure equates to the carrying value of assets at the balance sheet date:

2019
£000
2018
£000
Investments – (UK fi xed income securities)
Cash and cash equivalents 24,638 24,860
Other assets/(liabilities) ( 543) (179)
2 4,095 24,681

Cash balances were held on deposit with RBS and in the CGWL client account at 30 September 2019.

Fair value of fi nancial assets and fi nancial liabilities

Equity investments are held at fair value. No investments are held for trading purposes only.

Capital management policies and procedures

The current policy is to fund investments through equity. No future change to this policy is envisaged. As a public limited company, the Company is required to hold a minimum £50,000 share capital.

The Company's capital is summarised in notes 1 and 1 1 to these accounts. The Company has no debt and is fully funded by equity.

16. Dividends

2019
Ord
2018
Ord
£000 £000
Paid per share:
Final capital dividend of 2.25 pence for the year ended 30 September 2017
1,816
Paid per share:
Interim capital dividend of 1.75 pence for year ended 30 September 2018
3,106
Unclaimed dividends(1) (3)
Paid per share:(2)
Special capital dividend of 1.00 pence 1,772
Paid per share:
Final capital dividend of 2.65 pence for year ended 30 September 2018 5,370
Paid per share:
Interim capital dividend of 1.50 pence for year ended 30 September 2019 3,072
10,214 4,919
Paid per share:(3)
Special capital dividend of 1.75 pence
3,564
Proposed per share:
Final capital dividend of 2. 25 pence for the year ended 30 September 2019 4, 578
Proposed per share:
Final capital dividend of 2.65 pence for the year ended 30 September 2018 5,369

(1) Unclaimed dividends for a period of 12 years reverted to the Company

(2) Special capital dividend was paid on 24 October 2018

(3) Special capital dividend was paid after the year end on 28 November 2019

17. Post balance sheet events

Appointment of non-executive director

On 29 October 2019, Angela Henderson was appointed as a non-executive director. Further details can be found in the chairman's statement on page 5 and the Board of directors section on page 27.

Buybacks

Since the period end, a further 615,077 ordinary shares were purchased at an average price of 66. 78 pence per share and a total cost of £ 410,766.

Special dividend

On 31 October 2019 the Company announced a special dividend of 1.75 pence per share. The distribution returned to shareholders proceeds arising from the realisation of some of the Company's underlying investments. The payment was made on 28 November 2019 to shareholders on the register on 8 November 2019.

New investments

The Company has made the following investments since the period end.

Row Labels Sum of Amount
Invested £000
Investment
into existing
company
Qualifying companies 2,954
C4X Discovery Holdings plc 500 Yes
Cloudcall Group plc 1,154 Yes
Honest Brew Limited 300 Yes
Location Sciences Group plc 200 Yes
Osirium Technologies plc 800 Yes
Non-qualifying companies 4,691
Ascential plc 103 Yes
Cineworld Group plc 257 Yes
GoCo Group plc 217 Yes
Hiscox Ltd 405 No
Howden Joinery Group plc 483 No
Integrafi n Holdings plc 177 Yes
On The Beach Group plc 276 Yes
Liontrust Asset Management plc 17 No
Marlborough Special Situations Fund 1,015 Yes
Next plc 250 No
Sthree plc 528 No
Pennon Group plc 302 No
Tesco plc 382 Yes
Taylor Wimpey plc 279 No
Grand Total 7,646

Private company valuation reviews

The valuation of Infi nity Reliance Ltd (My 1st Years) was reviewed and adjusted down following a period of weak trading post period end. The downward revision to the share price, which equates to -£454,461 (-0.22 pence per share), was incorporated into the net asset value per share as at 30 November 2019, released on 13 December 2019. The valuation of My 1st Years and its contribution to the net asset value per share refl ects the performance of the Company at the balance sheet date.

Alternative performance measures

Alternative Performance Measure ("APM")

An alternative performance measure is a financial measure of the Company's historic or future financial performance, financial position or cash flows which is not defined or specified in the applicable financial reporting framework.

The Directors assess the Company's performance against a range of criteria which are viewed as particularly relevant for a VCT.

The definition of each APM is in the glossary of terms on page 69. Where the calculation of the APM is not detailed within the financial statements, an explanation of the methodology employed is below:

NAV total return since inception

30 September
2019
Net asset value per share A 70.60p
Dividends paid per share since inception B 55.15p
NAV total return since inception A+B 125.75p

Ongoing charges ratio

The ongoing charges ratio has been calculated using the AIC's "Ongoing Charges" methodology.

30 September
2019
£'000
Investment management fee 2,261
Other expenses(1) 677
VCT proportion of MSSF expenses 89
Ongoing charges
A
3,027
Average net assets
B
147,607
Ongoing charges ratio
(A/B)*100
2.05%

(1) Other expenses exclude the London Stock Exchange fee of £72k for admission of shares under the offer for subscription as the Board do not consider this cost to be an ongoing cost to the fund.

Share price discount

30 September
2019
Share price A 66.50p
Net asset value per share B 70.60p
(Discount)/premium [(A/B)-1]*100 (5.81%)

The 5 year average discount of 5.37% is calculated by taking the average share price discount between 1 October 2014 and 30 September 2019.

Glossary of terms

Qualifying Company or Qualifying Investment

An investment made by a venture capital trust in a trading company which comprises a qualifying holding under Chapter 4 of Part 6 ITA.

VCT or Venture Capital Trust

A Venture Capital Trust or VCT is a company, broadly similar to an investment trust, which has been approved by HMRC and which subscribes for shares in (or lends money to) small unquoted companies, including those quoted on AIM or NEX (formally ISDX). Under the VCT scheme, VCTs and their investors enjoy certain tax reliefs. The VCT scheme is designed to encourage investment in small unquoted companies. Individuals invest by holding shares in a VCT.

Revenue return

Revenue profi t/(loss) for the reporting period divided by the weighted average number of shares in issue.

Capital return

Capital profi t/(loss) for the reporting period divided by the weighted average number of shares in issue.

Combined return

Total profi t/(loss) for the reporting period divided by the weighted average number of shares in issue.

Alternative performance measures

An alternative performance measure is a fi nancial measure of the Company's historic or future fi nancial performance, fi nancial position or cash fl ows which is not defi ned or specifi ed in the applicable fi nancial reporting framework.

The Company uses the following alternative performance measures:

Net asset value (NAV)

The value of the Company's assets, less its liabilities.

Net asset value (NAV) per share

The net asset value divided by the total number of shares in issue.

Ongoing charges ratio

The ongoing costs of managing and operating the Company divided by its average net assets. Calculated in accordance with AIC guidance, this fi gure excludes 'non-recurring costs'.

Share price discount

The price of a share is derived from buyers and sellers agreeing a price at which to trade their shares. The share price may not be identical to the NAV per share of the underlying assets less liabilities of the Company. If the share price is lower than the NAV per share, the shares are trading at a discount. Shares trading at a price above NAV per share are said to be at a premium.

Total return

The NAV total return shows how the NAV per share has performed over a period of time in percentage terms taking into account both capital returns and dividends paid. We calculate this by adding the dividends paid in the period to the closing NAV per share and measuring the percentage change relative to the opening NAV per share.

Total return since inception

The sum of the published NAV per share plus all dividends paid per share over the lifetime of the Company.

Shareholder information

The Company's ordinary shares (Code: HHV) are listed on the London Stock Exchange. Shareholders can visit the London Stock Exchange website, www.londonstockexchange.com, for the latest news and share prices of the Company. Further information for the Company can be found on its website at www.hargreaveaimvcts.co.uk.

Net asset value per share

The Company's NAV per share as at 13 December 2019 was 69.90 pence per share. The Company publishes its unaudited NAV per share on a weekly basis.

Dividends

Subject to approval at the Annual General Meeting on 4 February 2020, the Board has proposed the payment of a fi nal dividend of 2. 25 pence in respect of the fi nancial year ending 30 September 2019.

Shareholders who wish to have future dividends paid directly into their bank account rather than sent by cheque to their registered address can complete a mandate for this purpose. Mandates can be obtained by contacting the Company's registrar, Equiniti.

Selling your shares

Hargreave Hale AIM VCT plc operates a share buy-back policy to improve the liquidity in its ordinary shares. Share buyback policies are subject to the Act, the Listing Rules and tax legislation, which may restrict the VCT's ability to buy shares back in. The policy is non-binding and is at the discretion of the Board.

The buyback policy targets a 5% discount to the last published NAV per share as announced on the London Stock Exchange through a regulatory news service provider. The discount is measured against the mid-price per share as listed on the London Stock Exchange and refl ects the price at which the Company buys its shares off the market makers. The Company publishes its unaudited NAV per share on a weekly basis.

VCT share disposals settle two business days post trade if the shares are already dematerialised or placed into CREST ahead of the trade, or ten days post trade if the stock is held in certifi cated form.

VCT share disposals are exempt of capital gains tax when the disposal is made at arms' length, which means a shareholder must sell their shares to a market maker through a stockbroker or another share dealing service. Investors who sell their VCT shares before the fi fth anniversary of the share issue are likely to have to repay their income tax relief. Canaccord Genuity Wealth Limited has particular expertise in the sale of VCT shares and is able to act for VCT shareholders who wish to sell their shares. However, you are free to nominate any stockbroker or share dealing service to act for you. If you would like Canaccord Genuity Wealth Limited to act for you as their client (as opposed to a shareholder in the Company) then please contact Andrew Pang for further information (020 7523 4872, [email protected]).

Please note that Canaccord Genuity Wealth Limited will need to be in possession of the share certifi cate and a completed CREST transfer form before executing the sale. If you have lost your share certifi cate, then you can request a replacement certifi cate from the Company's registrar Equiniti. The registrar will send out an indemnity form, which you will need to sign. The indemnity form will also need to be countersigned by a UK insurance company or bank that is a member of the Association of British Insurers. Since indemnifi cation is a form of insurance, the indemnifying body will ask for a payment to refl ect their risk. Fees will refl ect the value of the potential liability.

Shareholder enquiries:

For general shareholder enquiries, please contact Canaccord Genuity Wealth Limited on 01253 754755 or by e-mail to [email protected].

For enquiries concerning the performance of the Company, please contact the investment manager on 0207 523 4837 or by e-mail to [email protected].

Electronic copies of this report and other published information can be found on the Company's website at www.hargreaveaimvcts.co.uk.

Change of address

To notify the Company of a change of address please contact the Company's registrar at the address on page 71.

Company information

Secretary and registered offi ce Canaccord Genuity Wealth Limited 41 Lothbury London EC2R 7AE

Directors

Sir Aubrey Brocklebank, Chairman David Brock Oliver Bedford Ashton Bradbury Angela Henderson

Manager

Hargreave Hale Limited c/o 41 Lothbury London EC2R 7AE

Registrars

Equiniti Aspect House Spencer Road Lancing West Sussex BN99 6ZL

Administrator and Custodian Canaccord Genuity Wealth Limited c/o Talisman House Boardmans Way Blackpool FY4 5FY

Auditors BDO LLP 150 Aldersgate Street London EC1A 4AB

Solicitors

Dickson Minto W.S. 16 Charlotte Square Edinburgh EH2 4DF

VCT Status Adviser

Philip Hare & Associates Hamilton House 1 Temple Avenue London EC4Y 0HA

Brokers

Nplus1 Singer Capital Markets Limited One Bartholomew Lane London EC2N 2AX

Company Registration Number 05206425 in England and Wales

Notice of Annual General Meeting

NOTICE IS HEREBY GIVEN that the ANNUAL GENERAL MEETING of Hargreave Hale AIM VCT plc ("the Company") will be held at 41 Lothbury, London EC2R 7AE on 4 February 2020 at 10.30 am for the purposes of considering and if thought fi t, passing the following resolutions, of which resolutions 1 to 11 will be proposed as ordinary resolutions and 12 and 13 as special resolutions:

Ordinary Resolutions

    1. To receive and if thought fi t, to accept the Reports of the Directors and auditor and the audited fi nancial statements for the year ended 30 September 2019;
    1. To receive and approve the directors' remuneration report for the year ended 30 September 2019;
    1. To approve the directors' remuneration policy, the full text of which is contained in the directors' remuneration report for the year ended 30 September 2019;
    1. To reappoint BDO LLP as auditors to the Company and to authorise the Directors to determine their remuneration;
    1. To re-elect Aubrey Brocklebank as a director of the Company;
    1. To re-elect David Brock as a director of the Company;
    1. To re-elect Oliver Bedford as a director of the Company;
    1. To re-elect Ashton Bradbury as a director of the Company;
    1. To elect Angela Henderson as a director of the Company; and
    1. To approve a fi nal dividend of 2. 25 pence per ordinary share in respect of the year ended 30 September 2019.
    1. THAT, the directors be and are hereby generally and unconditionally authorised in accordance with section 551 of the Companies Act 2006 ("the Act") to exercise all the powers of the Company to allot ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") and to grant rights to subscribe for or convert any security into Ordinary Shares in the Company ("Rights") up to an aggregate nominal value of £100,000, this authority to expire on the earlier of the conclusion of the Company's next Annual General Meeting in 2021 and the expiry of 15 months from the passing of this resolution (unless previously revoked, varied or extended by the Company in general meeting), save that this authority shall allow the Company to make before the expiry of this authority offers or agreements which would or might require Ordinary Shares to be allotted or Rights to be granted after the expiry of such authority. The authority being sought under this resolution is in addition to any existing authorities.

Special Resolutions

    1. THAT, the directors be and are hereby empowered pursuant to section 570 and section 573 of the Act during the period commencing on the passing of this resolution and expiring on the conclusion of the Company's next annual general meeting in 2021 or on the expiry of 15 months from the date of the passing of this resolution, whichever is the earlier (unless previously revoked, varied or renewed by the Company in general meeting), to allot equity securities (as defi ned in section 560 of the Act) for cash pursuant to the authority given to directors pursuant to resolution 11 above, or by way of sale of treasury shares, as if section 561 of the Act did not apply to any such allotment or sale, save that this authority shall allow the Company to make offers or agreements before the expiry which would or might require Ordinary Shares to be allotted or sold and the directors may allot equity securities or sell shares after the expiry in pursuance of such offers or agreements as if the powers conferred hereby had not so expired. The power being sought under this resolution is in addition to for any existing powers.
    1. THAT, in substitution for any existing authority but without prejudice to the exercise of any such power prior to the date hereof, the Company be generally and unconditionally authorised to make one or more market purchases (within the meaning of section 693(4) of the Act) of Ordinary Shares on such terms and in such manner as the directors may determine (either for cancellation or for retention as treasury shares for future re-issue, transfer or cancellation) provided that:
  • a) the maximum aggregate number of Ordinary Shares authorised to be purchased shall not exceed 14.99% of the issued share capital at the date of the passing of this resolution . If this resolution had been passed at the date of this notice, the maximum aggregate number of shares would be 30, 489,553, but this fi gure will decrease proportionately if there is a decrease in the shares in issue between the date of this notice and the Annual General Meeting.
  • b) the maximum price which may be paid for an Ordinary Share is an amount equal to the maximum amount permitted to be paid in accordance with the rules of the UK Listing Authority in force as at the date of purchase;
  • c) the minimum price which may be paid for an Ordinary Share shall be 1p (the nominal value thereof);
  • d) this authority shall expire at the conclusion of the Company's next Annual General Meeting in 2021 or on the expiry of 15 months following the passing of the resolution, whichever is the earlier (unless previously revoked, varied or renewed by the Company in general meeting); and
  • e) the Company may make a contract or contracts to purchase Ordinary Shares under this authority before the expiry of the authority which will or may be executed or completed wholly or partly after the expiry of the authority and may make a purchase of Ordinary Shares in pursuance of any such contract or contracts.

Information regarding the Annual General Meeting, including the information required by section 311A of the Act, is available from www.hargreaveaimvcts.co.uk.

By order of the Board of Directors.

Canaccord Genuity Wealth Limited

Company Secretary

Registered Offi ce: 41 Lothbury London EC2R 7AE

1 9 December 2019

A member entitled to attend and vote at this meeting may appoint a proxy or proxies to attend and vote instead of him or her. A proxy need not also be a member of the Company. To be effective, forms of proxy together with the power of attorney or other authority, if any, under which it is signed, or a notorically certifi ed copy or a copy certifi ed in accordance with the Powers of Attorney Act 1971 of that power or authority must be lodged with the Company's Registrar, Equiniti, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA not less than 48 hours before the time appointed for holding the meeting or any adjournment thereof. Lodgement of the form of proxy will not preclude a member from attending the meeting and voting in person.

A member may appoint more than one proxy, provided each proxy is appointed to exercise rights attached to different shares. Members may not appoint more than one proxy to exercise rights attached to any one share.

The right to appoint a proxy does not apply to persons whose shares are held on their behalf by another person and who have been nominated to receive communications from the Company in accordance with Section 146 of the Act ("nominated persons"). Nominated persons may have a right under an agreement with the member who holds the shares on their behalf to be appointed (or to have someone else appointed) as a proxy. Alternatively, if nominated persons do not have such a right, or do not wish to exercise it, they may have a right under such an agreement to give instructions to the person holding the shares as to the exercise of voting rights.

The Company, pursuant to Regulation 41 of the Uncertifi ed Securities Regulations 2001 specifi es that only those members registered in the register of members of the Company as at 6.30pm on 31 January 2020 or, in the event that the meeting is adjourned, on the register of members at 6.30pm on the day 2 days prior to the reconvened meeting, shall be entitled to attend or vote at the aforesaid annual general meeting in respect of the number of shares registered in their name at that time. Changes to entries on the relevant registrar of securities after 6.30pm on 31 January 2020 (or in the event that the meeting is adjourned, as at 6.30pm 2 days prior to the adjourned meeting) shall be disregarded in determining the rights of any person to attend or vote at the meeting notwithstanding any provisions in any enactment, the Articles of Association of the Company or any other instrument to the contrary.

CREST members who wish to appoint a proxy or proxies through the CREST electronic proxy appointment service may do so for the meeting and any adjournment(s) thereof by using the procedures described in the CREST Manual (www.euroclear.com). CREST personal members or other CREST sponsored members who have appointed a voting service provider(s) should refer to their CREST sponsor or voting service provider(s), who will be able to take appropriate action on their behalf. In order for a proxy appointment or instruction made by means of CREST to be valid, the appropriate CREST message (a "CREST proxy instruction") must be properly authenticated in accordance with Euroclear's specifi cations and must contain the information required for such instructions, as described in the CREST Manual. The message must be transmitted so as to be received by Equiniti, the Company's Registrar (ID RA19), not later than 48 hours before the time appointed for meeting. For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp applied to the message by the CREST Applications Host) from which Equiniti is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST.

CREST members and where applicable their CREST sponsors or voting service provider(s) should note that Euroclear does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST proxy instructions. It is the responsibility of the CREST member concerned to take (or if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider(s), to procure that their CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members and where applicable, their CREST sponsors or voting service provider(s) are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.

A vote withheld is not a vote in law, which means that the vote will not be counted in the calculation of votes for or against the resolution. If no voting indication is given, the proxy will vote or abstain from voting at his or her discretion. The proxy will vote (or abstain from voting) as he or she thinks fi t in relation to any other matter which is put before the meeting.

The Company may treat as invalid a CREST proxy instruction in the circumstances set out in Regulation 35(5)(a) of the Uncertifi cated Securities Regulations 2001.

Under section 319A of the Companies Act 2006, the Company must answer at the Annual General Meeting any question a member asks relating to the business being dealt with at the Annual General Meeting unless:

  • answering the question would interfere unduly with the preparation for the meeting or involve the disclosure of confi dential information;
  • the answer has already been given on a website in the form of an answer to a question; or
  • it is undesirable in the interests of the Company or the good order of the meeting that the question be answered.

In accordance with Section 311A of the Companies Act 2006, the contents of this notice of meeting, details of the total number of shares in respect of which members are entitled to exercise voting rights at the Annual General Meeting and if applicable, any members' statements, members' resolutions or members' matters of business received by the Company after the date of this notice will be available on the Company's website http://www.hargreaveaimvcts.co.uk.

Members satisfying the thresholds in Section 527 of the Companies Act 2006 can require the Company to publish a statement on its website setting out any matter relating to the audit of the Company's accounts (including the auditor's report and the conduct of the audit) that are to be laid before the Annual General Meeting that the members propose to raise at the meeting. The Company cannot require the members requesting the publication to pay its expenses. Any statement required to be placed on the website must also be sent to the Company's auditor no later than the time it makes its statement available on the website. The business which may be dealt with at the meeting includes any statement that the Company has been required to publish on its website.

Shareholders (and any proxy or representatives they appoint) agree, by attending the meeting, that they are expressly requesting that they are willing to receive any communications (including communications relating to the Company's securities) made at the meeting.

You may not use any electronic address provided either in this notice of meeting or any related documents (included in the form of proxy) to communicate with the Company for any purpose other than those expressly stated.

Note:

    1. The following documents will be available for inspection at the registered offi ce of the Company during usual business hours on a weekday (except Saturdays, Sundays and Public Holidays) until the date of the meeting and at the place of the meeting for a period of 15 minutes up to and during the meeting;
  • a) copies of the directors' letters of appointment;
  • b) the articles of association of the Company; and
  • c) the register of directors' interests in the shares of the Company.
    1. As at 1 8 December 2019 (being the latest business day prior to the publication of this Notice), the Company's issued share capital consists of 203, 399,290, carrying one vote each. Therefore, the total voting rights in the Company are 203, 399,290.

Hargreave Hale AIM VCT plc (Incorporated in England and Wales under the companies act 1985 with registered number 05206425)

Talk to a Data Expert

Have a question? We'll get back to you promptly.